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Shape matters: synthesis and biomedical
applications of high aspect ratio magnetic
nanomaterialsQ1
Raluca M. Fratila,*a,b Sara Rivera-Fernándeza and Jesús M. de laQ2 Fuente*a,c,d
High aspect ratio magnetic nanomaterials possess anisotropic properties that make them attractive for
biological applications. Their elongated shape enables multivalent interactions with receptors through the
introduction of multiple targeting units on their surface, thus enhancing cell internalization. Moreover,
due to their magnetic anisotropy, high aspect ratio nanomaterials can outperform their spherical ana-
logues as contrast agents for magnetic resonance imaging (MRI) applications. In this review, we first
describe the two main synthetic routes for the preparation of anisotropic magnetic nanomaterials: (i)
direct synthesis (in which the anisotropic growth is directed by tuning the reaction conditions or by using
templates) and (ii) assembly methods (in which the high aspect ratio is achieved by assembly from indivi-
dual building blocks). We then provide an overview of the biomedical applications of anisotropic magnetic
nanomaterials: magnetic separation and detection, targeted delivery and magnetic resonance imaging.
1. Introduction
Nanomaterials possess unique physicochemical properties
that differ considerably from those of the corresponding bulk
material. These novel chemical, optical, electronic or magnetic
properties have been applied in different fields, ranging from
optoelectronics and magnetic devices to catalysis and biomedi-
cine. Taking into account the fact that the sizes of most bio-
logically relevant molecules and structures fall within the
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nanoscale dimension, it comes as no surprise that interfacing
nanomaterials with biology and medicine have led to some of
the most promising applications of nanotechnology in the
past two decades.
Historically, research on nanomaterials for biomedical
applications has focused on spherical nanomaterials (e.g. gold
nanoparticles, quantum dots and magnetic nanoparticles).
More recently, high aspect ratio nanomaterials such as nano-
wires, nanorods, nanotubes or linear assemblies of nanoparti-
cles (nanochains) have begun to receive attention because of
their elongated geometry, which translates into magnetic,
optical, electrical or chemical anisotropy. As a consequence of
their anisotropic properties, high aspect ratio nanomaterials
are likely to interact with biological entities in completely
different ways than their spherical counterparts. For instance,
some high aspect ratio nanomaterials (carbon nanotubes1,2
and filament-shaped polymer micelles3) have been reported to
have a considerably longer blood half-life than spherical nano-
particles, which was attributed to the slower uptake of such
nanostructures by macrophages. This has important conse-
quences for biomedical applications because a long circulation
time in the bloodstream is a key requirement for in vivo target-
ing, imaging and delivery using nanomaterials.1–6 Moreover,
shape anisotropy offers new possibilities for functionalization
towards bioapplications. On the one hand, the large surface
area of these nanostructures offers the possibility of multi-
valent interactions between targeting ligands and receptors,
thus facilitating cell internalization.4,5,7 On the other hand,
heterostructured multi-segment nanowires can be selectively
functionalized with different biomolecules to enhance their
biocompatibility or targeting ability.8
This review describes recent advances in the field of
magnetic high aspect ratio nanomaterials. We chose to focus
only on magnetic nanomaterials based on the fact that
spherical magnetic nanoparticles have shown the most prom-
ising bioapplications so far when compared to other nano-
structured materials, for example in magnetic hyperthermia
therapy of cancer, targeted drug delivery, tissue engineering,
bioseparations and biosensing, as well as in the field of con-
trast agents for magnetic resonance imaging.9–16 Therefore, we
expect a similar interest in growth regarding anisotropic mag-
netic nanomaterials. In addition to the above-mentioned
general features of high aspect ratio nanomaterials (longer
blood circulation time and the possibility of multivalent and/
or selective biofunctionalization), magnetic anisotropy is
attractive for magnetic resonance imaging (MRI) applications,
as well as for magnetic separation and manipulation. Due to
linear clustering, some high aspect ratio magnetic nanomater-
ials showed increased transverse relaxivity when compared to
their spherical counterparts.4,17,18 Anisotropic magnetic nano-
materials have higher magnetic moments than spherical ones
and therefore can be manipulated using weaker magnetic
fields, opening up new possibilities for magnetic targeted
delivery and therapy, as well as for magnetic cell separation.8
The review is organised as follows. We start by presenting the
main classes of high aspect ratio magnetic nanomaterials to
be discussed in this work and the synthetic methods that
allow for their fabrication. To facilitate the reading, we include
for each nanomaterial, immediately after describing its syn-
thesis, a brief discussion of its magnetic properties and how
these are influenced by anisotropy. We then give an overview
of the applications of high aspect ratio nanomaterials in bio-
medicine. We wrap up the discussion with a brief summary
and a critical perspective of the field.
2. Synthesis and magnetic properties
of high aspect ratio magnetic
nanomaterials
During the last decade, the nanotechnology nomenclature has
been enriched with terms such as “nanotubes”, “nanowires”,
“nanochains”, “nanoworms”, “nanobars”, “nanorods” and
“nanoneedles”, to name but a few. These names are generally
related to the shape of nanomaterials rather than to their
actual aspect ratio and chemical structure and, to date, there
is no universal nomenclature accepted for non-spherical nano-
materials.19 The aspect ratio is determined by dividing the
major axis of a shape by the width of its minor axis. Hence, a
sphere has an aspect ratio of 1. Although some authors con-
sider that nanowires have a higher aspect ratio than nano-
rods,20 there is no strict differentiation between these two
nanostructures.21 In this review we will employ the nomen-
clature reported by different authors and we will discuss three
main geometries of high aspect ratio magnetic nanomaterials:
nanowires/nanorods, nanotubes and chain- or worm-like
assemblies (Fig. 1; see Table 1 for a summary of the types of
high aspect ratio nanomaterials that form the subject of this
discussion).
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It is rather difficult to classify the synthetic approaches
used to obtain high aspect ratio magnetic nanomaterials, as
many different methodologies have been addressed. Generally,
they can be divided into two main classes: direct synthesis (the
morphology is controlled during the synthesis by tuning the
synthetic conditions or by using appropriate templates) and
assembly methods (the high aspect ratio nanomaterial is
assembled from individual building blocks, either during the
synthesis or in a post-synthetic step). However, some examples
of hybrid synthetic methods involving the use of nucleic acids
or carbon nanotube templates together with spherical mag-
netic nanoparticles can be found in the literature. For the sake
of uniformity, we will discuss these more exotic approaches
(ref. 58,60–64) at the end of section 2.1.2, together with classi-
cal template-assisted synthesis. In general, direct synthesis
leads to tube-, rod- and wire-like magnetic nanomaterials,
while nanostructures such as nanochains and nanoworms are
obtained by assembly methods. An overview of these synthetic
methods is given as follows, discussing their advantages and
drawbacks. Many articles report only the synthesis of high
aspect ratio nanomaterials, without further exploring their
bioapplications. Therefore, we will highlight some synthetic
procedures that yielded high aspect ratio nanostructures
with potential bioapplications, but our focus will be on
the synthesis of high aspect ratio nanomaterials that have
already been tested for biomedical applications. Whenever
possible, we will provide insights into the mechanisms
proposed for the formation of different types of anisotropic
nanostructures.
2.1 Direct synthesis
2.1.1 Chemical synthesis. The aspect ratio of nanomater-
ials can be tailored by fine-tuning synthetic parameters such
as reaction media, ratio and concentration of precursors and/
or reagents, reaction time, temperature and so forth. Impor-
tantly, the surface chemistry of the nanomaterial, which is fun-
damental for future biomedical applications (see section 3)
can be also controlled during the synthesis. In this section, we
discuss relevant literature examples reporting on strategies to
promote the growth of the anisotropic magnetic nanomaterials
of different morphologies and aspect ratios. These strategies
involve different chemical methods, from co-precipitation to
thermal decomposition of precursors, microemulsion and
hydrothermal growth. Although it seems generally accepted
that the crystallization process governs the growth of 1D nano-
structures, the exact mechanisms of formation of such nano-
structures are often not fully understood. In this section, we
will present and discuss the mechanisms reported in the lit-
erature; for further details of strategies to control the growth of
high aspect ratio nanomaterials (although not focused on
magnetic anisotropic nanomaterials), we direct interested
readers to the review of Xia et al.22
Fig. 1 High aspect ratio nanomaterials discussed in this work and their
biomedical applications.
Table 1 Types of high aspect ratio magnetic nanomaterialsa
Type of nanomaterial
Chemical
composition Synthetic method Aspect ratio Magnetic properties Ref.
Nanotubes, nanorods IO Hydrothermal 2,7 Ferromagnetic 23,24
Nanorods IO Microwave-assisted
reduction
3 Ferromagnetic 25
Nanorods IO Co-precipitation 2 Superparamagnetic 27
Nanorods, nanowhiskers IO Thermal decomposition 5; 10; 4 (Super)paramagnetic/
ferromagnetic
30,31,33
Nanowires IO Microemulsion >100 Superparamagnetic/
ferromagnetic
32
Nanowires IO Ultrafiltration Tuneable
(4–10)
— 35
Nanorods nanowires Ni, Au–Ni, IO Porous membranes-
templated
Tuneable — 40–52
Nanotubes, nanowires IO, Co IO, Au–(Co)
IO
Carbon nanotube/
DNA-templated
— Superparamagnetic 54–65
Nanochains, nanowires,
nanorods
IO, FeNi3 Magnetic assembly Tuneable
(4–20)
Superparamagnetic/
ferromagnetic
67–70,73–79,81,82
Nanoworms, nanochains IO, Co IO Polymer assembly,
self-assembly
— Superparamagnetic 4,5,88
Nanochains IO Covalent linking 3–5 Superparamagnetic 89,91
a IO: Iron oxide (α-Fe2O3: hematite; γ-Fe2O3: maghemite; Fe3O4: magnetite).
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Wu et al. reported a systematic study of the effect of several
parameters (concentrations of ferric ions and additives, reac-
tion time) on the size and morphology of iron oxide nanoparti-
cles obtained by the hydrothermal treatment of FeCl3 in the
presence of sulphate and phosphate additives.23 By tuning the
reaction times and the concentration of ferric chloride, the
authors were able to control the shape of hematite (α-Fe2O3)
nanoparticles, as shown in Fig. 2a. Short magnetite nanotubes
(SNTQ3 ) with an aspect ratio of 2 (see Fig. 2b for representative
SEM and TEM images) were obtained at long reaction times
(6–12 h) and a concentration of FeCl3 of 0.04 M. Moreover, the
geometry of the resulting nanostructures was also affected by
the type and ratio of the additives used (Fig. 2c), with phos-
phate ions playing a crucial role in inducing shape anisotropy.
This observation is in line with a previous literature report by
Brown and co-workers, who attributed the formation of
α-Fe2O3 nanorods to the preferential adsorption of the phos-
phate surfactant to the c-axis of α-Fe2O3, which promoted the
growth of rod-like structures.24 Importantly, the hematite SNTs
synthesised by Wu et al. could be transformed into the corres-
ponding magnetite (Fe3O4) and maghemite (γ-Fe2O3) nano-
structures by annealing under a reducing atmosphere with
retention of their size and morphology. In terms of magnetic
properties, both magnetite and maghemite nanotubes showed
a ferromagnetic behaviour, with a higher saturation magneti-
zation (Ms) value for the Fe3O4 ones. Although no applications
are reported in this study, the authors note that both types of
short nanotubes could have potential for bioseparations
because of their good magnetic response. The nanotubes
could be quickly separated in the presence of a magnet and
easily re-dispersed by simple shaking.
Microwave-assisted synthesis of nanomaterials is becoming
increasingly popular, following a similar trend in organic
chemistry. Motte and co-workers synthesized magnetic nano-
rods by a two-step one-pot procedure involving the microwave
reduction of precursor nanorods obtained in the first step.25
In this case, the shape control is achieved during the synthesis
of the precursor (akaganeite β-FeOOH) using dopamine, which
is known for its strong affinity for Fe(III). In the absence
of dopamine ligands, mainly hexagonal nanoparticles were
Fig. 2 Anion-controlled synthesis of short magnetic nanotubes. (a) Shape evolution of hematite nanostructures with time and ferric ions concen-
tration. (b) Top and centre: SEM and low magnification TEM images of nanotubes. Bottom: high-resolution TEM (HRTEM) image of a single hematite
nanotube. Scale bar of the inset in the HRTEM picture is 2 nm. (c) Formation process of hematite structures mediated by phosphate and sulphate
anions. Reprinted with permission from ref. 23. Copyright 2010, American Chemical Society.
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obtained, while its presence promoted the growth of rod-
shaped nanoparticles whose aspect ratio was inversely pro-
portional to the reaction times, decreasing from 5.8 after 2 h
reaction time to 4.6 after 4 h. Dopamine plays here a similar
role to that of phosphate ions in the above-discussed
examples,23,24 favouring the growth of rod-like structures along
the c-axis of the β-FeOOH crystal. In the second step, micro-
wave irradiation at 100 °C and 200 W promoted the reduction
of β-FeOOH to Fe3O4/γ-Fe2O3 nanorods, as shown by XRD ana-
lysis. Interestingly, the geometry of the final particles strongly
depended on the reaction conditions. After four microwave
cycles the rod-like geometry was attained, although the
aspect ratio decreased from 5.8 to 3.2, suggesting that the
reduction took place through a dissolution–recrystallization
mechanism. However, six or eight microwave cycles resulted
in a shape change from rods to hexagonal nanoparticles.
Tartaj and co-workers reported a similar approach for control-
ling the morphology in the first step of the synthetic
process.26 Their simple procedure for the synthesis of nano-
rods and nanorices with tuneable surface chemistry consisted
in preparing rod- and rice-like goethite nanoparticles by
aerobic oxidation of FeSO4 and coating them with an in-
organic alumina or zirconia layer. Finally, to promote the for-
mation of superparamagnetic iron oxide spinels, the
nanorods were heated under a H2 atmosphere. The choice of
the coating layer was motivated by the potential biological
applications of these nanostructures. The fact that alumina
is positively charged at physiological pH could favour
their cellular uptake by negatively charged membranes, while
zirconia could be functionalized with phosphate moieties for
improved stability and functionality.
Nath et al. developed a simple, high-yield and scalable
water-based synthesis of dextran-coated iron oxide (DION)
superparamagnetic nanorods.27 The protocol involves a typical
co-precipitation of Fe(II) and Fe(III) salts in the presence of a
base (ammonium hydroxide). Interestingly, the addition of the
polymer 30 s after the beginning of the nucleation process
favoured the formation of monodisperse rod-shaped magnetite
nanocrystals (aspect ratio of 2.3), whereas when the dextran
was present in the reaction medium from the beginning of the
synthesis, poorly crystalline spherical nanoparticles were
obtained. Although no detailed growth mechanism was pres-
ented, the purity and size distribution of the polymer seemed
to play a key role in controlling the morphology of the nano-
particles. High purity dextran with a narrow size distribution
was assumed to bind to the surface of iron oxide nanocrystals,
directing the preferential growth of nanorods, whilst less pure
dextran polymers displaying two main populations seemed to
interfere with the directional growth process and yielded poly-
disperse spherical iron oxide nanoparticles. The superpara-
magnetic behaviour of the nanorods was attributed to the
presence of magnetite in their structure, which was confirmed
by both X-ray diffraction data and X-ray photoelectron spec-
troscopy (XPS). Importantly, the DION rods synthesised by
adding dextran at 30 and 60 s from the beginning of the reac-
tion showed high transverse relaxivities (R2 ≈ 300 mM−1 s−1),
which makes them promising candidates for magnetic reson-
ance imaging and sensing applications.
Thermal decomposition of Fe(III) organic complexes (iron
oleate and iron acetylacetonate) in the presence of oleic acid
and oleylamine is usually the method of choice for the syn-
thesis of spherical iron oxide nanoparticles because it pro-
duces nanoparticles with excellent crystallinity and very
narrow size distribution.28,29 However, to date, there have been
only scarce reports on the use of this methodology for the syn-
thesis of anisotropic iron oxide nanomaterials. This could be
related to an insufficient understanding of the growth mechan-
ism, including the role of reaction parameters such as tem-
perature and ligands. Starting from iron oleate and sodium
oleate as precursors, Bao et al. were able to tune the aspect
ratio of γ-Fe2O3 nanorods by controlling the reaction tempera-
ture, observing that the higher the temperature, the lower the
aspect ratio of the obtained rods.30 The authors also reported
the effect of the precursors on the morphology of the resulting
nanoparticles as replacement of sodium oleate by oleic acid
resulted in only spherical nanocrystals. Palchoudhury et al.
reported recently the first synthesis of ultrathin elongated iron
oxide nanostructures called “nanowhiskers” by thermal
decomposition of Fe(III) oleate (Fig. 3a).31 The authors con-
ducted a comprehensive mechanistic study to account for the
role of the ligands in the growth process. Density functional
theory (DFT) calculations (Fig. 3b) revealed that the Fe(III)
oleate complex has a quasi-octahedral structure with two of
the three oleate ligands having much lower binding energies
(7.0 and 10.5 eV) than the third one (39.2 eV). Thermogravi-
metric analysis (TGA) experiments provided further confir-
mation of this difference in the ligand coordination
environment, with two regions which could be clearly attribu-
ted to the loss of the two weakly bound ligands between 150
and 230 °C (Fig. 3c, region a) and to the decomposition of the
third ligand at 230–295 °C (Fig. 3c, region b). In light of these
results, the authors postulated that the third oleate ligand
plays a critical role in directing the growth of the nanowhis-
kers. Their hypothesis was supported by the fact that thermal
decomposition using Fe(II) oleate (which has two ligands with
similar binding energies) as the precursor instead of Fe(III)
oleate yielded only irregularly shaped, aggregated nanoparti-
cles. Furthermore, experiments performed using surfactants
that have a weaker, respectively a stronger binding to iron
oxide nanoparticles than oleic acid (trioctylphosphine oxide
(TOPO) and oleylamine (ON Q4), respectively) produced nano-
structures with similar whisker shapes. These nanowhiskers
did not contain any traces of TOPO or oleylamine on their
surface, as indicated by their infrared spectra, further confirm-
ing that the third oleate ligand directs the formation of such
high aspect ratio nanostructures.
Yang and co-workers demonstrated the effect of annealing
temperature on the morphology and chemical structure of
magnetic nanowires.32 Iron(II) oxalate dihydrate nanowires
with a diameter of 100 nm and lengths of several tens of
micrometres were firstly synthesized by microemulsion and
subsequently annealed at different temperatures and under
Nanoscale Review
This journal is © The Royal Society of Chemistry 2015 Nanoscale, 2015, 00, 1–28 | 5
1
5
10
15
20
25
30
35
40
45
50
55
1
5
10
15
20
25
30
35
40
45
50
55
different atmospheres. In air at 550 and 700 °C, respectively,
porous α-Fe2O3 nanowires maintaining the morphology of the
FeC2O4·H2O precursor were obtained. However, when the
annealing was performed at 400 °C under an Ar/H2 atmos-
phere, Fe3O4 nanowires were obtained, as indicated by TEM
and infrared spectroscopy. Yet another example of how the
reaction temperature can control the shape, structure and
magnetic properties of magnetic nanomaterials was reported
by Zhang et al. for the thermal decomposition of Fe(acac)3.33
When the reaction was carried out in water at 140 °C for 12 h
in a sealed autoclave, uniformly sized superparamagnetic
hematite nanorods were obtained. However, increasing the
temperature to 180 °C led to different morphologies of hema-
tite nanostructures, depending on the reaction time: mixtures
of nanorods and spherical nanoparticles after 3 h and nano-
cubes after 8 h. On the other hand, direct thermolysis of the
Fe(acac)3 precursor in air at 300 °C for 3 h resulted in quadrate
maghemite nanocrystals displaying a ferromagnetic behaviour.
Ionic liquids (ILs) can be successfully used as solvents for
the thermal decomposition of Fe(CO)5 to regulate the shape
and chemical composition of the obtained iron oxide nanopar-
ticles, as reported by Lee and co-workers.34 Interestingly, when
ionic liquids alone were used as the reaction medium, only
maghemite nanobars were obtained. When the synthesis was
carried out in mixtures of IL and dimethylformamide (DMF) at
ratios of 1 : 1.5 and 1 : 3, the formation of magnetite aniso-
tropic nanoparticles (nanobars, respectively nanowires) was
observed by TEM. Moreover, the ILs also acted as surface
stabilizers, eliminating the need for additional surfactants
typically employed in thermal decompositions. The examin-
ation of the magnetic properties of the maghemite nanobars
by superconducting quantum interference device (SQUID)
magnetometry revealed that they were superparamagnetic;
moreover, they showed potential for use as contrast agents for
MRI. However, the authors did not conduct a comparative
study on the magnetic behaviour of the corresponding magne-
tite high aspect ratio nanoparticles.
In a rather original approach, Chang et al. employed ultra-
filtration for the synthesis of γ-Fe2O3 nanowires coated with a
biocompatible polymer (chitosan) in a simple, one-step, room
temperature co-precipitation of Fe(II) and Fe(III) salts.35 In this
case, the tangential force is driving the formation of elongated
nanoparticles, while the concentration of the NaOH solution
plays a key role in controlling their size and shape. At low
NaOH concentrations (5% w/w), rod-like particles with an
aspect ratio of 4 were formed. A gradual increase in the con-
centration of NaOH resulted in the formation of nanowires
with aspect ratios higher than 10.
2.1.2 Template-assisted synthesis. This synthetic approach
makes use of premade nanoporous templates (hard templates)
or biomolecules (soft templates) to control the morphology
and aspect ratio of nanomaterials. Hard templates usually
consist of rigid materials (zeolites, alumina, and block copoly-
mer films) containing pores or channels and have the advan-
tage of a good control over the size and dispersity of the final
nanomaterials. Nevertheless, their synthesis can be time-con-
suming and expensive. Soft templates such as biological
macromolecules and pre-ordered polymeric structures can act
as templates only (meaning that they are removed after syn-
thesis to afford the stand-alone inorganic magnetic nano-
material). However, their chemical properties can be
advantageously used for tuning the solubility, biocompatibility
and surface functionality of the resulting hybrid organic–
inorganic nanoconstructs. For comprehensive reviews on tem-
plate-directed synthesis of different classes of magnetic, but
also non-magnetic nanomaterials, interested readers can refer
to several literature reviews.36–39
Electrodeposition of metallic salts inside alumina or poly-
carbonate porous membranes is one of the most popular
methods to grow both single-segment and multi-segment
Fig. 3 (a) TEM image of iron oxide nanowhiskers and HRTEM inset. (b)
Optimised structure of the Fe(III) oleate complex. (c) TGA plot revealing
the thermal decomposition behaviour of the iron oleate complex. Re-
printed with permission from ref. 31. Copyright 2011, American
Chemical Society.
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nanowires in hard templates. Electrochemical deposition is
fast, relatively easy to perform and does not require expensive
instrumentation or high pressure and temperature conditions.
Typically, in the first step of the process a thin film of metal is
deposited on one face of the template to serve as a working
electrode. A sacrificial metal layer can be introduced before the
deposition step in order to avoid deformations at one end
of the rods or wires. Then, the deposition of the desired
material(s) is performed and in the final steps the working
electrode, sacrificial layer and template are dissolved to release
the high aspect ratio nanostructures (Fig. 4).
Several authors applied this method for the synthesis of
magnetic nickel nanowires40–42 and multifunctional magnetic
gold–nickel nanowires43–45 in large quantities and with excel-
lent monodispersity. Moreover, by tuning the chemical compo-
sition of Ni/Cu nanowires, Reich and co-workers demonstrated
that it is possible to tailor their magnetic properties.46 Nano-
wires fabricated by electrodeposition into polycarbonate mem-
branes showed different magnetic responses to an external
magnetic field depending on the aspect ratio of the Ni and Cu
layers. Nanowires containing rod-shaped layers (diameter
100 nm, length 1000 nm, aspect ratio of 10) aligned parallel to
the magnetic field, while nanowires with disc-shaped layers
(diameter 100 nm, length 10 nm, aspect ratio of 0.1) aligned
perpendicular to the applied field. Pondman et al. synthesised
short (2.6 ± 0.3 μm, 150 nm diameter) superparamagnetic
Ni nanowires by electrodeposition inside polycarbonate
membranes.47 After dissolution of the membrane, the nano-
wires were further coated with a gold layer to increase their
biocompatibility.
Another methodology to construct high aspect ratio nano-
materials using hard templates consists in the vacuum-
assisted infiltration of the components in the pores of the tem-
plate. McCarthy et al. synthesised multimodal (magnetic and
fluorescent) nanowires by infiltrating a THF solution of poly-
styrene, fluorescent coumarin-153 dye and spherical oleic acid-
coated 12 nm magnetite nanoparticles into 200 nm porous
alumina membranes.48 The free nanowires were obtained after
dissolving the membrane with NaOH, as in the case of electro-
deposition methods. The initial spherical magnetite nanopar-
ticles showed a typical superparamagnetic behaviour, with an
Ms value of 48.5 emu g−1 comparable to previous reports on
NPs synthesised in a similar fashion, as observed from vibrat-
ing sample magnetometry (VSM) experiments.49 Unfortunately,
the magnetic characterization of the nanowires by VSM was
impossible due to practical difficulties related to the geometry
of the material. Although the authors conducted a VSM
measurement using a polystyrene film loaded with magnetite
(with an identical loading to that of the nanowires) and
observed a much lower Ms value (5.2 emu g−1) and a small loss
of the superparamagnetic behaviour, it is not clear to what
extent these data are relevant for the magnetic behaviour of
the nanowires. Prina-Mello and co-workers used the same
vacuum-assisted infiltration procedure for the preparation of
silica nanowires (lengths of 8 ± 2 μm, diameters of 176 ±
50 nm) loaded with magnetite nanoparticles.50 The authors
compared the magnetic properties of the silica nanowires with
those of their spherical counterparts, silica-coated magnetite
nanoparticles (144 ± 15 nm). The spherical nanostructures
showed higher Ms values and a higher content of magnetite
than the nanowires; therefore, the benefits of shape anisotropy
were not evident in terms of magnetic behaviour. However, the
nanowires showed a clear advantage over spherical nanoparti-
cles in terms of surface functionalization with antibodies,
aggregation behaviour and flow cytometry applications (see
section 3).
Magnetic nanotubes consisting of silica nanotubes coated
with Fe3O4 nanoparticles on their inner surface were prepared
by Lee and co-workers by a “surface sol–gel” method using
porous alumina templates of different diameters (60 and
200 nm).51 The iron oxide nanoparticles present inside the
nanotubes were clearly visible on TEM images. Their presence
was further confirmed by the superparamagnetic behaviour of
the nanotubes, deducted from their room-temperature magne-
tization curves measured in a superconducting quantum inter-
ference device (SQUID). The saturation magnetization values
obtained for the 60 and 200 nm nanotubes (2.7 and 2.9 emu
g−1, respectively) are in agreement with the values previously
reported for magnetite-coated spherical silica nanoparticles
(3.2 emu g−1).52 Interestingly, this method also allows for a
differential functionalization of the inner surface of the mag-
netic nanotubes for biomedical applications (see section 3).
In a different approach, magnetite tubular nanostructures
were obtained in a process involving pulsed-laser deposition of
Fe3O4 onto MgO nanowires, followed by selective etching of
the magnesium oxide cores.53 This simple technique generates
single crystalline Fe3O4 nanotubes with excellent size homo-
geneity and controllable dimensions (length, diameter and
thickness).
Carbon nanotubes (CNTs) are excellent scaffolds or tem-
plates for the construction of anisotropic nanomaterials
because of their large surface area. Hybrid CNTs–iron oxide
nanomaterials combine the advantages of each individual
component and could be promising candidates for different
biomedical applications, including MRI, magnetic hyperther-
mia treatment and drug delivery. Several methods are reported
Fig. 4 General scheme describing the fabrication of nanorods/nano-
wires by electrodeposition into nanoporous templates. Reprinted from
ref. 37 with permission from John Wiley & Sons.
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to date for the introduction of magnetic nanoparticles on the
surface of CNTs. Most of them consist in the in situ prepa-
ration of the magnetic nanoparticles via co-precipitation of
Fe(II) and Fe(III) salts or thermal decomposition of precursors
in the presence of the CNTs. Yang and co-workers obtained
hydrophilic superparamagnetic multiwalled (MW) CNT/Fe3O4
hybrids by a classical solvothermal method using diethanol-
amine to control the growth of the nanoparticles and to
prevent their aggregation.54 However, TEM images recorded at
high magnification revealed the presence of nanoclusters com-
posed of several nanocrystals of Fe3O4 on the surface of the
MWCNTs (Fig. 5a and b). The good water colloidal stability of
the hybrids was attributed to the presence of diethylene glycol
(used as a solvent) and diethanolamine on the surface of the
nanotubes. Alternatively, polymers grafted onto the surface of
the CNTs can be used not only to increase the stability of the
magnetic nanotubes in water, but also to ensure a more
uniform deposition of the Fe3O4 nanoparticles and to provide
reactive groups for further (multi)functionalization.55
Magnetic MWCNT hybrids can also be synthesised by
thermal decomposition of ferrocene at 425 °C, resulting in the
attachment of iron oxide nanoparticles onto the surface of the
nanotubes.56 In this case, XRD, XPS and Raman spectroscopy
experiments revealed that the magnetic material present on
the CNTs was mainly Fe2O3. The main disadvantage of this
method when compared to the solvothermal procedure
reported by Yang was that the as-synthesised magnetic nano-
tubes were not easily dispersible in water, therefore requiring
additional polymer coating to render them suitable for biologi-
cal applications.
Recently, Lamanna et al. reported the preparation of
MWCNTs decorated with iron oxide nanoparticles (NPs), inves-
tigating two different synthetic routes based on ligand
exchange or click chemistry, respectively.57 Ligand exchange
between CNTs bearing carboxyl groups and oleic acid-coated
NPs (CNT-IO 1) resulted in a high loading of nanoparticles on
the nanotube surface; moreover, the NPs showed a high ten-
dency to form aggregates (see Fig. 5c). In contrast, click chem-
istry ligation between azide-functionalized iron oxide NPs and
alkyne-modified CNTs allowed for a much better control of the
anchoring of NPs onto the surface of the nanotubes and pre-
vented aggregation (CNT-IO 2, Fig. 5d). The authors postulated
that the different aggregation behaviour observed using the
two different strategies was directly related to the number of
reactive groups available for functionalization on the surface
of the CNTs, being the number of COOH groups per gram of
nanotubes much higher than that of alkyne moieties, as calcu-
lated from TGA experiments. The field-dependent magnetiza-
tion curve of CNT-IO 1 showed a superparamagnetic behaviour
at 300 K. Besides, the saturation magnetization value of this
Fig. 5 (a), (b) TEM and HRTEM images of hydrophilic MWCNT/Fe3O4 hybrids showing iron oxide nanoparticle clustering on the surface of the CNTs.
Reprinted from ref. 54, H. Wu et al., The behavior after intravenous injection in mice of multiwalled carbon nanotube/Fe3O4 hybrid MRI contrast
agents, Biomaterials, 2011, 32, 4867–4876, Copyright 2011, with permission from Elsevier. (c), (d) Ligand exchange and click chemistry ligation strat-
egies for the synthesis of CNT–iron oxide nanoparticle hybrids. Reproduced from ref. 57 with permission from The Royal Society of Chemistry.
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CNT–IO hybrid was practically the same as that of NPs alone
(53 emu g−1 vs. 52 emu g−1).58 This indicates that the magnetic
properties of the iron oxide nanoparticles are maintained after
their conjugation to the CNTs. The authors evaluated the
potential of CNT-IO 1 as a contrast agent for MRI (see section
3); however, they did not conduct a further systematic investi-
gation of the magnetic properties and potential biological
applications of both magnetic CNT hybrids. Therefore, a direct
comparison of their magnetic properties and interaction with
cells and how these are affected by differences in the density
and homogeneity of the surface coverage with NPs is not
within reach.
Nature offers a large diversity of structures able to function
as biological templates for the synthesis of anisotropic mag-
netic nanomaterials. Among biomolecules, DNA has been
extensively used as a soft template to assemble 1D magnetic
nanostructures. Byrne et al. prepared magnetite nanowires
using herring sperm DNA (hs-DNA).59 The nanowires were
assembled in situ from spherical Fe3O4 nanoparticles with a
diameter of 9 ± 2 nm, obtained by co-precipitation of Fe(II) and
Fe(III) salts in the presence of DNA. Interestingly, the use of
double-stranded DNA induced the formation of entangled
chains, while heat-denatured DNA (single-stranded) promoted
a more ordered assembly (Fig. 6a and 6c). Under the influence
of an external magnetic field oriented perpendicular to the
samples, a further alignment of the single-stranded DNA-mag-
netite chains was observed, resulting in the formation of ropes
with lengths of several microns (Fig. 6b). By contrast, the mor-
phology of the double-stranded DNA-magnetite nanocon-
structs was not affected by the exposure to an external
magnetic field (Fig. 6d). These DNA-magnetite hybrids showed
an unusual magnetic behaviour, with very high longitudinal
(r1) relaxivity at low magnetic fields, especially in the case of
the single-stranded constructs. This behaviour is completely
unexpected for pure superparamagnetic samples and was
attributed to the more ordered aggregation of the NPs along
the single-stranded DNA scaffold.
Ivanisevic and co-workers reported several examples of
DNA-templated hybrid nanoparticle chains starting from indi-
vidual spherical gold, iron oxide and/or cobalt iron oxide
Fig. 6 Anisotropic magnetic nanomaterials created using DNA templates. TEM images of magnetic nanowires assembled on single-stranded (top)
and double-stranded (bottom) herring DNA in the absence (a, c) and in the presence of an external magnetic field (b, d). Reproduced from ref. 59
with permission from The Royal Society of Chemistry. (e) Schematic representation of the fabrication of Au-magnetic nanoparticle chains on DNA.
(f ) Layer-by-layer encapsulation of multicomponent Au–iron oxide nanochains. Reproduced from ref. 65 with permission from The Royal Society of
Chemistry and ref. 60, Copyright 2010, American Chemical Society.
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nanoparticles.60–65 The method employed to construct the
DNA-nanoparticle hybrids is summarized in Fig. 6e. In the
first step, positively charged nanoparticles were self-assembled
using the negative backbone of DNA and then the chains were
cut into shorter strands by the action of restriction enzymes
such as EcoRI. For the construction of multicomponent
chains, Au and magnetic short strands were joined together
using a ligase. To enhance their cellular uptake, the resulting
chains were further encapsulated using a layer-by-layer (LBL)
approach (Fig. 6f), in which negatively and positively charged
polymers were alternatively wrapped around the chains and
the outermost polymer layer was decorated with targeting
ligands such as RGD peptides. This system presents several
advantages, as it requires relatively cheap starting materials, is
performed at room temperature in aqueous media and allows
for a flexible design of the components. Moreover, a multifunc-
tional platform for biological applications can be created, by
combining the MRI contrast enhancement induced by the
magnetic NP component with controlled drug delivery from
the Au NP segment. Another remarkable feature of this design
is the fact that the chain lengths and the amount of magnetic
nanoparticles (which is ultimately responsible for the contrast
in MRI) can be fine-tuned through the synthesis.62 In all their
studies, the authors observed increased transverse relaxivity
values for the DNA-NP chains when compared to spherical
single components. Interestingly, although in general the LBL
encapsulation of the DNA-NP chains led to a decrease in the
transverse relaxivity in water and MRI phantoms, this differ-
ence was not significant for 3D cell culture phantoms (see
section 3.5). In this case the contrast in MRI was given by the
amount of contrast agents internalized by cells; therefore the
improved cellular uptake of the encapsulated chains could be
responsible for the observed results.64 Although the anisotropy
clearly induced better magnetic properties, the authors reason
that in this case the cell internalization was improved by the
presence of targeting ligands on the chains, rather than by the
shape of the nanostructure.
2.2 Assembly methods
One-dimensional assemblies of magnetic nanoparticles can be
obtained in a variety of ways, the most common being mag-
netic dipole–dipole interaction, self-assembly processes
(usually mediated by polymers) and covalent chemical linkage.
In many cases a cooperative combination of an external mag-
netic field (to pre-align the nanoparticles) and a polymer (to
act as a linker and hold the nanoparticles together in a linear
chain-like conformation) is used. An evident advantage of
some assembly methods (such as zero-field assembly and
covalent linkage) over direct synthesis is the fact that the dia-
meter of the resulting high aspect ratio nanomaterial is dic-
tated by the diameter of the individual building blocks,
enabling the construction of materials with diameters down to
a few nanometres. On the other hand, the synthetic procedures
can be sometimes cumbersome and might require additional
synthetic steps and/or advanced functionalization of the indi-
vidual nanoparticles.
2.2.1 Magnetic assembly
Zero-field assembly. The formation of linear chains in the
absence of an external field if magnetic dipole–dipole inter-
actions between individual nanoparticles are sufficiently
strong was predicted more than three decades ago by theore-
tical calculations.66 This linear assembly is expected when the
dipolar coupling constant λ, which depends on the size of the
nanoparticle, has values superior to 2. However, direct evi-
dence of the existence of such magnetic structures was not
provided until the early 2000s, when Philipse and co-workers
reported cryo-TEM images of magnetite chains assembled
under zero-field conditions from individual 21 nm spherical
nanoparticles (Fig. 7a and b).67 The authors clearly demon-
strated that the driving force for the assembly was the dipolar
interaction between nanoparticles, which depends on the size
of the nanoparticles. While 21 nm nanoparticles (λ ≈ 7)
assembled in linear chains, 16 nm nanoparticles (λ ≈ 2)
formed only droplet-shaped aggregates.
Meng et al. obtained highly uniform 1D magnetic nano-
chains following a simple, one-pot procedure using FeCl3,
sodium oleate and standard surfactant molecules (oleic acid
and oleylamine).68 The nanochains were composed of polyhe-
dron-shaped α-Fe2O3 nanoparticle units with an average dia-
meter of 19.8 nm and excellent uniformity (Fig. 7c). A close
look at the contact region between two contiguous nanoparti-
cles by high-resolution TEM (HRTEM, Fig. 7d) and the corres-
ponding reversed-phase fast-Fourier-transform (FFT) pattern
demonstrated the single-crystal nature of the junction area.
The authors reasoned that in the initial stages of the synthesis
(when the concentration of the precursors is high), metastable
polyhedron-shaped particles stabilized by capping of oleic acid
and oleylamine on their surface are formed under a kinetic
growth regime. These initial nanocrystals have a high free
energy, especially when looking at the atoms located at their
corners. As the reaction proceeds, the concentration of the pre-
cursors decreases and further evolution of the nanoparticles
into chains is governed by the minimization of the overall
surface energy: atoms might migrate from higher energy posi-
tions to lower ones, thus causing the transition areas to dis-
solve and promoting the linear growth of the nanochains
(Fig. 7e). A similar process was observed by Palchoudhury et al.
during the thermal decomposition of iron oleate in the pres-
ence of a weakly bound surfactant, trioctylphosphine oxide
(TOPO).69 Time-dependent studies revealed that spherical
maghemite nanoparticles are formed at short reaction times
(1 h), whereas at longer reaction times these aggregate into
high aspect ratio structures (nanoworms) with the same dia-
meter (12 nm) as the spherical nanoparticles.
Jia et al. reported a rapid and economical procedure for the
synthesis of FeNi3 nanochains by reduction of Fe(III) and Ni(II)
precursors in the presence of hydrazine and under microwave
irradiation.70 Several parameters were found to play a key role
in the process: a moderate microwave intensity was necessary
to ensure the growth of magnetic nanochains of high purity,
while the diameter of the nanoparticles (and therefore the
diameter of the chains) could be controlled by adjusting the
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concentrations of the Fe and Ni precursors. The nanochains 
revealed a ferromagnetic behaviour and their saturation mag-
netization was found to be 350 times higher than that of the 
corresponding spherical FeNi3 nanoparticles. The authors 
reasoned that the anisotropic structure of the chain was at the 
origin of this behaviour. However, none of the synthetic pro-
cedures discussed in ref. 68-70 attributes the chain formation to 
the magnetic dipole–dipole coupling mentioned by Philipse. 
Therefore, it is difficult to establish a size limit below which 
individual NPs cannot self-assemble into chain-like structures 
without the aid of an external magnetic field.
Magnetic-field-induced assembly. Magnetic-field-induced (MFI)
assembly of nanoparticles is one of the most widely exploited
routes for the fabrication of ordered structures (for detailed
overviews of the subject, see the reviews of Yin and co-
workers71,72). The initial building blocks can be synthesised
in situ or in a previous synthetic step. Many MFI assembly pro-
cedures employ polymers to “glue” together the nanoparticles
by electrostatic interactions. These examples will be discussed
in this section and not in section 2.2.2, where we will cover
encapsulation in polymers as a stand-alone method to gen-
erate magnetic anisotropic structures.
Sheparovych et al. used magnetic field-induced assembly to
construct magnetite nanowires.73 Superparamagnetic spherical
nanoparticles capped with citric acid (which provides them
with a negative surface charge) were linked together using
a positively charged polyelectrolyte, poly(2-vinyl-N-methyl-
pyridinium iodide). The reaction was carried out inside a
plastic cell mounted on top of a magnet; in a control experi-
ment performed in the absence of an external magnetic field,
only random arrays of iron oxide nanoparticles were observed
by TEM. VSM measurements demonstrated that the nanowires
preserved the superparamagnetic properties of individual
building blocks.
Electrostatic interactions between magnetic nanoparticles
and polymers can be exploited to construct colloidal assem-
blies, as shown by Berret and co-workers. In a first study, rod-
like structures were assembled by mixing solutions of poly(tri-
methylammonium ethylacrylate methylsulfate)-b-poly(acryl-
amide) and polyacrylic acid-coated maghemite nanoparticles
and dialysing the resulting mixture under a constant magnetic
field of 0.1 T.74 It is noteworthy that when the dialysis was
carried out in the absence of a magnetic field, only spherical
aggregates were obtained. Once again, the high aspect ratio
nanostructure maintained the superparamagnetism of the
spherical nanoparticles. This methodology was extended to
the preparation of bimodal superparamagnetic–fluorescent
nanorods assembled from anionic iron oxide and organic fluo-
rescent nanospheres in the presence of a cationic block copoly-
mer.75 A comprehensive study on the cellular uptake, toxicity
and degradation of magnetic nanowires assembled from
γ-Fe2O3 nanoparticles and poly(trimethylammonium ethylacry-
late)-b-poly(acrylamide) was further reported by the same
group (see section 3).76
Fig. 7 Representative TEM (a) and cryoTEM (b) images of 21 nm magnetite nanoparticle chains assembled under zero-field conditions. Reprinted
with permission from ref. 67. Copyright 2004, American Chemical Society. (c) and (d) TEM image of maghemite nanochains and representative
HRTEM picture of the contact area between two contiguous nanoparticles and the corresponding FFT pattern. (e) Proposed mechanism for the
growth of the nanochains. Reprinted with permission from ref. 68. Copyright 2010, American Chemical Society.
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Fragouli et al. reported on the use of MFI to create nano-
composite polymeric (poly(ethylmethacrylate-co-methyl-
acrylate), PEMMA) films incorporating nanowire arrays of
γ-Fe2O3 nanoparticles of 10 nm mean diameter.77 The nano-
wires retained the superparamagnetism of the spherical nano-
particles and presented magnetic anisotropy. Magnetization
values measured with a magnetic field parallel to the nano-
wires were higher than that when the field was oriented per-
pendicular to the wires, consistent with previous reports of
Sahoo et al.78 and Sheparovych et al.73 In a follow-up study, the
same authors reported a theoretical investigation of the aggre-
gation of individual spherical superparamagnetic nanoparti-
cles under the influence of an external magnetic field.79 The
study was conducted for 11 and 17 nm iron oxide nanoparti-
cles capped with oleic acid, using a Monte Carlo method.
Simulations were carried out both in the absence and in the
presence of a magnetic field and predicted a much clearer
aggregation tendency for the bigger particles. The formation of
chains starting from 10 nm nanoparticles, observed in their
previous work,77 was attributed to the presence of the polymer,
which can reduce inter-particle electrostatic interactions and
favour the aggregation into clusters. Moreover, from Monte
Carlo simulations of SQUID experiments with parallel and per-
pendicular orientations of the applied magnetic field a ratio
between parallel and perpendicular magnetization of 2.5 ± 1.1
for the 11 nm nanoparticles was calculated, in line with the
experimental value of 1.9 ± 0.3 obtained for the chains of
10 nm iron oxide nanoparticles.
Yin and co-workers reported the synthesis of responsive
photonic nanochains composed of superparamagnetic Fe3O4
colloidal nanocrystals (CNCs)80 using a sol–gel synthesis
assisted by an external magnetic field.81 The process is sche-
matically described in Fig. 8a. The key step is the application
of an external magnetic field for a short period of time during
the silica coating to induce the assembly of the individual
nanoparticles into chains, which were further coated with an
additional silica layer for stability purposes. The procedure
yields robust chain-like structures, persistent after the removal
of the magnetic field (Fig. 8b); moreover, it allows a high
degree of control over the structural features of the chains. By
fine-tuning the exposure time to the magnetic field the
authors were able to control the length of the chains, while
adjusting the time-points of magnetic exposure enabled
control over the interparticle distance. These magnetically
responsive photonic nanochains could find applications in
biosensing.
Not only individual magnetic nanoparticles, but also small
clusters of NPs can be assembled into ordered chains by
applying an external magnetic field, as shown by the work of
Wang et al.82 In this approach, nanoclusters with an average
Fig. 8 (a) Schematic illustration of the fabrication of 1D nanochains of Fe2O3 nanoparticles by aggregation in the presence of an external magnetic
field H. (b) Representative TEM image of 1D nanochains. Reprinted with permission from ref. 81 with permission from John Wiley & Sons. (c) For-
mation mechanism for nanochains composed of clusters of magnetic nanoparticles. Stage I: thermal decomposition of ferrocene; stage II: formation
of clusters; stage III: chain assembly under the influence of the external magnetic field. (d) and (e) TEM images of chains with different intercluster
spacings (1 and 2 in the insets indicate electron diffraction pattern and lattice fringe, respectively). Reprinted with permission from ref. 82. Copyright
2009, American Chemical Society.
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diameter of 120 nm were synthesised starting from ferrocene 
and then assembled into chains using an external magnetic 
field (Fig. 8c). The length of the chains was affected by the 
magnetization time, with practically all the individual NPs 
assembled into chains after 16 h of exposure to the external 
magnetic field. The strength of the magnetic field had a clear 
influence on the formation of highly ordered structures, as the 
application of a magnetic field of 0.2 T resulted in a much more 
ordered chain than that of 0.1 T. Finally, the amount of 
hydrogen peroxide used for the synthesis of the spherical NPs 
influenced not only the distance between adjacent nanoclus-
ters in the chains, but also the chemical composition of the 
nanoparticles. A molar ratio of H2O2–ferrocene of 40 : 1 pro-
duced pure magnetite nanoparticles assembled in chains with 
an intercluster distance of 8 nm (sample S1, Fig. 8d). However, 
when the amount of H2O2 was doubled the resulting nanopar-
ticles consisted of a mixture of maghemite, magnetite and 
hematite and the spacing between adjacent clusters increased 
to 17 nm (sample S2, Fig. 8e). The authors postulated that the 
shorter intercluster distance in the sample that contained only 
magnetite clusters could be explained by a stronger attraction 
between the nanoparticles. This was reflected in the saturation 
magnetization values, which were slightly higher for sample S1 
(55 emu g−1) than for sample S2 (46 emu g−1). Based on the 
fact that individual nanoparticles were smaller than 20 nm 
and therefore superparamagnetic, the authors predicted a 
similar magnetic behaviour of the nanochains. However, mag-
netic measurements revealed a weak ferromagnetic character 
of the chains. This transition from superparamagnetism to 
ferromagnetism was attributed to the formation of 1D 
chains,83 showing how shape anisotropy can be used to 
manipulate the magnetic properties of the material.
2.2.2 Self-assembly
Polymer-assisted assembly. Polymers are commonly used in
the synthesis of magnetic nanomaterials for stabilisation and
biocompatibility purposes. However, they can also play a sig-
nificant role in tuning the morphology and magnetic pro-
perties of the obtained nanomaterials. By controlling the ratio
between maleic anhydride grafted polypropylene (PP-g-MA)
and the iron precursor (Fe(CO)5), Wei and co-workers obtained
superparamagnetic α-Fe2O3 hollow spheres (weight ratio PP-g-
MA/Fe(CO)5 = 1 : 3.5), or ferromagnetic nanowires composed
of core–shell γ-Fe2O3 nanoparticles when the ratio of PP-g-MA/
Fe(CO)5 was changed to 1 : 14.84 The authors explained the
nanowire formation by a self-assembly process driven by mag-
netic dipole–dipole interactions between nanoparticles and
van der Waals forces between the surrounding polymer mole-
cules. More recently, the same group demonstrated that by
changing only the molecular weight of polypropylene grafted
with terminal maleic anhydride (PP-MA) it is possible to
control the structure, size and morphology of the individual
iron oxide building blocks, as well as the magnetic properties
of the resulting nanochains.85 When using a low molecular
weight polymer (Mw = 2500 Da), thermal decomposition of
Fe(CO)5 resulted in nanochains composed of spherical γ-Fe2O3
nanoparticles of 24 nm diameter and showing a ferromagnetic
“hard” character (coercivity of 292.7 Oe). By contrast, nano-
chains with a ferromagnetic “soft” behaviour (coercivity of 70.5
Oe) were assembled from slightly bigger (30 nm diameter)
flower-like γ-Fe2O3 nanoparticles in the presence of a higher
molecular weight PP-MA (Mw = 8000 Da). The different mor-
phology of the nanoparticles was attributed to the different
capping strengths of the polymers, which are directly related
to the density of maleic anhydride groups. These act as
capping ligands for the nanoparticles in a similar fashion to
typical carboxylic acid ligands. Since the mass of polymer used
is the same for both syntheses (0.25 g), for the 8000 Da PP-MA
less maleic anhydride groups were available in the reaction
medium, inducing the growth of small flower-like clusters of
NPs. When 2500 Da PP-MA was used only individual spherical
nanoparticles were formed because of a stronger capping.
Importantly, this one-pot colloidal synthesis enabled gram-
scale production of such magnetic colloids with potential
sensing applications.
In 2008 Sailor and co-workers reported the first example of
iron oxide “nanoworms” (NWs) synthesised by a modified co-
precipitation method using higher Fe(II) and Fe(III) salt concen-
trations and 20 kDa molecular weight dextran to induce the
linear assembly of 5–10 iron oxide cores.4 Although the
authors did not carry out an in-depth study of the aggregation
mechanism, they suggest that the key factor was the molecular
weight of the polymer. Their reasoning was based on the fact
that highly branched structures with a broader size distri-
bution were obtained when 40 kDa molecular weight dextran
was used, while 10 kDa dextran typically promotes the for-
mation of spherical nanoparticles.86 The nanoworms displayed
slightly higher saturation magnetization than their spherical
counterparts, as well as higher transverse relaxivity values,
demonstrating the effect of the shape anisotropy on their
magnetic properties. A further investigation of the magnetic
properties of the nanoworms revealed that their transverse relax-
ivity increased linearly with the magnetic field, which indicated
that they could find promising applications as MRI contrast
agents.18 As a matter of fact, these nanoconstructs represent
one of the most prolific examples of anisotropic magnetic nano-
particles with biomedical applications (see section 3).
Corr et al. reported the synthesis of linear assemblies of
magnetite nanoparticles prepared by co-precipitation of
FeCl3·6H2O and FeCl2·4H2O in the presence of a polyelectrolyte
(poly(sodium-4-styrene sulfonate), PSSS), at different Fe :
monomer ratios (1 : 2, 3 : 1, 6 : 1).17 The polyelectrolyte acted
both as a stabilising agent, its negatively charged backbone
promoting the aggregation of positive Fe ions, and as a tem-
plate by directing the assembly of the resulting iron oxide
nanospheres into chain-like structures. The chain-like mor-
phology was observed by TEM when the samples were dried in
the absence of an external magnetic field; however, upon
drying in a 0.5 T magnetic field these linear chains further
aligned to form parallel arrays of wire-like structures. The
authors also reported preliminary results regarding the poten-
tial use of these nanocomposites as MRI contrast agents (see
section 3).
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Liu and co-workers reported a two-step route to synthesise
superparamagnetic anisotropic structures (“nanoworms”) by
precipitation polymerization of divinylbenzene (DVB) in the
presence of previously synthesised 10 nm oleic acid-coated
Fe3O4 nanoparticles.87 The elongated structures were not
formed by individual nanoparticles, but by clusters of approxi-
mately 80–100 nm. The authors proposed a mechanism in
which Fe3O4–PDVB nanocomposites were formed at an initial
stage, followed by aggregation probably due to magnetic
dipole–dipole interactions. The nanoworms showed superpara-
magnetic behaviour at room temperature, but ferromagnetism
at 5 K. Although the authors envisaged possible applications
for drug delivery and MRI, no further studies were conducted
to this end.
Self-assembly of amphiphilic nanoparticles. In a recent report,
Bishop and co-workers showed that gold amphiphilic nanopar-
ticles functionalized with hydrophobic and hydrophilic
ligands can self-assemble into short chains in which the par-
ticles are held together by hydrophobic interactions.88 This
self-assembly takes place if the nanoparticles have an “adap-
tive” surface chemistry, with ligands that are not bound in an
irreversible manner to the NP surface and are able to rearrange
during the assembly process in order to minimize the number
of hydrophobic ligand–water contacts. By adjusting the
amount of hydrophobic ligands, the preferred coordination
number of the nanoparticles could be varied from 1 (dimers)
to 2 (linear chains) and 3 (clusters); moreover, high salt con-
centrations were necessary for the formation of chains (most
likely by limiting repulsive electrostatic interactions only to the
nearest neighbours). This controlled self-assembly was further
extended to obtain linear chains of 8 nm superparamagnetic
CoFe2O4 nanoparticles functionalized with hydrophobic (1,2-
hexadecanediol, HDD) and hydrophilic (10,11-dihydroxyun-
decanoic acid, DHUA) ligands. At a HDD ligand coverage frac-
tion of 0.2, these nanoparticles assembled into linear chains,
as revealed by cryo-TEM images. The authors reasoned that
the formation of chains could not be attributed to magnetic
dipolar interactions between the CoFe2O4 nanoparticles
because at this particle size the strength of dipole–dipole inter-
action is not sufficient to promote a magnetic assembly. There-
fore, the chain formation was explained by hydrophobic
interactions between the HDD ligands. This hypothesis was
confirmed by the fact that no chains were observed in the
absence of HDD.
2.2.3 Covalent chemical linkage. Selective functionali-
zation of nanoparticle surfaces can enable the construction of
anisotropic structures via covalent bond formation. Peiris et al.
used a solid-phase synthesis strategy to obtain iron oxide
nanospheres with asymmetric surface chemistry, which were
further assembled into linear chains in a controlled fashion
(Fig. 9a).89 Amine-modified iron oxide nanoparticles were
attached to a solid phase functionalized with a homobifunc-
tional cleavable cross-linker containing disulfide bonds; cleav-
age from the resin yielded nanoparticles with asymmetric
surface functionalization. The procedure was repeated until
reaching the desired chain length. This methodology,
although more time consuming, allows a good control over the
length and aspect ratio of the nanochains and could be
extended to the preparation of hybrid nanostructures (e.g.
chains assembled from iron oxide nanoparticles and lipo-
somes90). Another interesting feature is the fact that the par-
tially modified area (PMA, the area capable of binding to a
solid support) of the nanoparticle depends on its size, as well
as on the length of the linker and the polymer chosen as
tether. This provides excellent flexibility and the ability to fine-
tune the surface asymmetry according to a rational design.
The nanochains outperformed their constituting spherical
components in terms of magnetic properties. For instance, a
nanochain composed of three 30 nm spheres showed a 2.25-
fold increase in the value of transverse relaxivity at 1.4 T.
In a very elegant approach, Stellacci and co-workers created
covalent chains of superparamagnetic iron oxide nanoparticles
by taking advantage of polar point defects present on the
surface of γ-Fe2O3 nanoparticles capped with two different
ligands (nonanoic acid and 4-phenylbutyric acid).91 In their
previous work, the authors showed that when spherical gold
nanoparticles were coated with two ligands of different lengths,
they arranged in a unique rippled fashion on the surface of
the nanoparticle, resulting in striated domains (Fig. 9b).92
This arrangement generates two diametrically opposed point
defects that can be used for place-exchange reactions with
molecular linkers to create 1D chains of nanoparticles92,93
and is independent of the nature of the metallic core, as
demonstrated further for iron oxide nanoparticles. When the
mixed-ligand coated γ-Fe2O3 nanoparticles were reacted with a
bifunctional linker, 11-(10-carboxy-decyldisulfanyl)-undecanoic
Fig. 9 Covalent nanoparticle chains. (a) Nanospheres with asymmetric
surface chemistry assembled into nanochains by solid-phase synthesis.
(b) Representative TEM image of the nanochains. Reprinted with per-
mission from ref. 89. (c) Side-view and top-view of rippled γ-Fe2O3
nanoparticles coated with mixed ligands. (d) Formation of 1D chains by
reaction of the nanoparticles with the molecular linker and TEM picture
of the chains (e). Reprinted from ref. 91 with permission from John
Wiley & Sons.
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acid (Fig. 9c), chains with an average length of 4 nanoparticles
(≈100 nm) were observed by TEM (Fig. 9d). The authors
demonstrated the covalent nature of the chains by performing
several control experiments. No chains were formed in the
absence of the linker or when a monofunctional linker was
used; importantly, the reaction of the linker with homoligand
capped γ-Fe2O3 nanoparticles also did not yield chains of
nanoparticles, since such nanoparticles lacked the ripple
structure that generates the point defects. Moreover, because
of the size of the nanoparticles the formation of the chains
via magnetic dipole–dipole interactions was also ruled out, as
this mechanism would require larger nanoparticles; see the
discussion in section 2.2.1. The chains showed superpara-
magnetic behaviour at room temperature and a larger increase
in their magnetization at increasing applied magnetic field
when compared to isolated spherical nanoparticles.
3. Biomedical applications
As already mentioned in the Introduction section, anisotropic
nanomaterials are expected to have a different interaction with
biological systems than their spherical analogues. The biologi-
cal applications of high aspect ratio magnetic nanomaterials,
although less numerous than those of spherical magnetic
nanoparticles, have often shown clear advantages that were
related to their anisotropic properties. It is reasonable to
assume that once we will manage to develop more general,
robust, effective and high-scale synthetic methods, the use of
these nanomaterials in biomedicine will become more
widespread.
3.1 Surface functionalization
Chemical modification of the surface of nanomaterials is
essential for providing them with the desired biological func-
tionality and for ensuring their biocompatibility and stability
in physiological media. Nanomaterials designed for biomedi-
cal applications must be able to overcome several biological
barriers before reaching their target and must preserve the pro-
perties of the inorganic core and the attached biomolecules.
Although our understanding regarding the biological fate of
nanomaterials has improved significantly over the last decade,
there are still many unknown aspects related to the toxicity of
nanomaterials and their interaction with biological entities.
A detailed discussion regarding the biofunctionalization of
nanomaterials is outside the scope of the present review.
Therefore, in this section we briefly address some key issues
and we provide more details when presenting the biomedical
applications of high aspect ratio magnetic nanomaterials. For
exhaustive revisions we direct the reader to a number of rele-
vant literature reviews on the topic.16,94–103
There are several important aspects to be taken into
account when considering the interaction of nanomaterials
with living systems (Fig. 10).100 Appropriate coating of nano-
particles is crucial in order to prevent adverse effects related
with adsorption of serum proteins (opsonization). This protein
adsorption represents the first immune response of the body
and can lead to aggregation of nanoparticles and to their sub-
sequent recognition by phagocytes. Surface coating with
passive targeting elements such as biocompatible polymers
and carbohydrates can also act as a “shield” to render the
nanoparticles invisible to the immune system, thus increasing
their blood circulation time. Importantly, coating provides
functional groups for anchoring therapeutic and active target-
ing elements (e.g. antibodies, cell-penetrating peptides or
tumour targeting units). Last but not least, potential cytotoxic
effects of nanomaterials can also be related to their surface
functionalization. On the one hand, coating can improve the
biocompatibility of nanomaterials and prevent leakage of in-
organic or organic cytotoxic elements. On the other hand,
however, certain types of coating materials can enhance toxi-
city. Nanomaterials containing cationic polymer coatings have
generally shown higher in vitro toxicity than neutral or anionic
ones. Their cytotoxic effects range from defects in lipid mem-
branes to cell lysis, apoptosis and necrosis and have been
associated with higher extent of cell internalization of cationic
nanomaterials.
3.2 Interaction of high aspect ratio magnetic nanomaterials
with living systems: cellular uptake, biodistribution and
toxicity aspects
To date, information concerning cellular uptake mechanisms,
cytotoxicity, biodistribution and degradation of magnetic an-
isotropic nanomaterials is rather limited when compared to
spherical nanoparticles. Given the broad size distribution of
high aspect ratio magnetic nanomaterials, with lengths
ranging from a few tens of nanometres to several micrometres,
it is even more difficult to generalize and predict the way they
Fig. 10 Overview of nanomaterial–biological entities interactions and
tips for functionalization. Green: protein adsorption can induce aggre-
gation and promote recognition by the immune system. Blue: potential
toxic effects associated with decomposition of the nanomaterial.
Orange: surface functionalization for active targeting. Yellow: surface
passivation to avoid recognition and clearance by the immune system.
Reprinted from ref. 100 with permission from John Wiley & Sons.
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will interact with living entities. Some early studies suggested
that Ni magnetic nanowires were internalized by fibroblast
cells following the integrin-mediated phagocytosis pathway
and established that the cellular uptake was maximized when
the length of the nanowires matched the diameter of the
cells.41 Likewise, Song et al. proposed that the mechanism of
uptake of iron nanowires by HeLa cells depends on the length
of the nanomaterial.104 Short nanowires with lengths between
hundreds of nanometres to a few micrometres were most likely
internalized by non-specific pinocytosis, while longer nano-
wires could perforate the cell membrane and diffuse through
it in a similar way to that reported for carbon nanotubes.105
Cytotoxicity assays revealed that the Fe nanowires were gener-
ally benign to the cells, only showing a slight cytotoxic effect at
increased concentrations and upon prolonged exposure times.
Magnetic Ni nanowires reported by Chen and co-workers106
also showed little to no toxicity when internalized by fibro-
blasts, as inferred from an assessment of gene expression of
IL-6 (a pro-inflammatory cytokine that is upregulated in fibro-
blasts as a result of trauma), as well as from MTT (3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) cell
viability assays. However, magnetic actuation on the interna-
lized nanowires by the application of an external magnetic
field could induce cell death by disrupting the intracellular
environment.
McCarthy et al. demonstrated that the cellular uptake of
magnetic-fluorescent nanowires was dependent not only on
their aspect ratio, but also on the surface functionalization.48
Plain polystyrene-coated wires showed practically no inter-
action with A549 cells, as opposed to nanowires functionalized
with anti-ICAM-1 (intracellular adhesion molecule 1) anti-
bodies. Depending on their lengths, these were either interna-
lized (“short” nanowires with aspect ratio <50) or attached to
cell membranes by binding to the ICAM-1 surface receptor
(“long” wires, aspect ratio >50). Similarly, short (2.6 μm) Au-
coated Ni nanowires functionalized with polyethylene glycol
and glutathione were internalized by macrophage RAW 264.7
cells, most likely via phagocytosis.47 These nanowires showed
good biocompatibility, as demonstrated by a comprehensive
cell viability study carried out on several cell types. Non-coated
Ni nanowires generally displayed higher cytotoxicity than Au–
Ni nanowires; however, in this study the concentration of the
Ni nanowires was much higher than the lethal concentration
of similar 20 μm Ni nanowires,42 indicating the importance of
tailoring the length to increase the biocompatibility of such
aspect ratio nanomaterials. Although in general an appropriate
polymer coating is required to ensure the biocompatibility of
nanomaterials, bare FeNi3 nanochains synthesised by Jia et al.
showed very low in vivo cytotoxicity in zebrafish larvae, with
more than 90% survival even after 96 h of exposure at concen-
trations of 50 mg L−1.70
Perhaps the most representative examples of how the
surface functionalization in combination with the shape aniso-
tropy can influence cell internalization can be found in the
work of Sailor and co-workers.4,5 In a proof of principle study,
iron oxide nanoworms decorated with multiple copies of
fluorescent cell-penetrating peptide F3, which is known to 
selectively target cell-surface receptors in tumour cells, showed 
increased cellular uptake in MDA-MB-435 human carcinoma 
cells when compared to F3-functionalized nanospheres 
(Fig. 11a). Moreover, cell uptake did not affect the nanoworm 
shape, as demonstrated by TEM analysis of the nanomaterials 
recovered both from cells and from the bloodstream after 24h. 
Although both nanospheres and nanoworms showed similar 
blood circulation times (15–18 h) and biodistribution in mice, 
the nanoworms were eliminated from tumours much slower 
than the nanospheres, indicating their potential to function as 
more effective delivery and/or imaging agents. In a more sys-
tematic work, the same authors explored different targeting 
elements (positively charged F3 peptide recognising cell 
surface vs. neutral CREKA peptide that targets clotted plasma 
proteins in tumours), peptide surface coverage and 
functionalization chemistry (longer PEG vs. shorter sulfo-
SMCC linkers) and shape (nanoworms vs. nanospheres) for the 
targeting of two types of mouse xenograft tumours 
(MDA-MB-435 human carcinoma and HT1080 human fibrosar-
coma) (see Fig. 11b).5 Elongated structures demonstrated 
again their superiority in terms of in vivo tumour targeting 
ability and blood half-life, while the smaller CREKA peptide 
was found to be more effective than F3 for tumour targeting, 
probably because F3-nanoworms were rapidly cleared from the 
blood (1 h) when compared to CREKA-nanoworms (circulation 
times >10 h). Using a longer PEG linker for the peptide attach-
ment improved the targeting efficiency of CREKA-nanoworms. 
The targeting efficiency of both tumours was optimal for a 
nanoworm decorated with ≈60 CREKA peptides (designated as 
NW-P175-C), with a larger uptake in the case of HT1080 cells. 
In terms of biodistribution, most of the CREKA-nanoworms 
were found in the liver and spleen of the mice. Fluorescence 
images of tumours collected 24 h after injection of NW-P175-C 
revealed different localization of the nanomaterial, depending 
on the type of tumour: nanoworms were found in large blood 
vessels in MDA-MB-435 tumour cells, respectively in smaller 
vessels and tumour stroma in HT1080 cells. The authors pos-
tulated that the larger uptake observed in the case of HT1080 
tumour can be attributed to a self-amplifying process induced 
by the binding of CREKA to clotted plasma proteins present in 
this type of tumour.
Ivanisevic and co-workers also showed that the introduction
of RGD peptides as targeting moieties for the integrin cell-
surface receptors of HT-29 human colon cancer cells led to an
enhanced uptake of LBL-encapsulated DNA-templated Au–iron
oxide nanoparticle chains.63,64 The authors carried out a com-
parative in vitro study using the HT-29 cell line (human colon
cancer cells) to evaluate the cytotoxicity and cellular uptake of
nanoparticles alone, DNA-templated nanochains (1 : 1
DNA : NP ratio, where NP = Au, Fe2O3 or CoFe2O4) and LBL
encapsulated DNA-templated nanochains functionalized with
RGD on their outermost layer.63 NPs alone induced mitochon-
drial damage, while DNA-templated nanochains showed no
cytotoxic effect after 3 days of incubation. Moreover, the cellu-
lar uptake was significantly improved after LBL encapsulation
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and introduction of RGD moieties, respectively. The cytotox-
icity of the nanochains was assessed after the addition of each
polymer layer without observing any significant decrease in
cell viability. This is promising towards in vivo applications, as
it suggests that degradation of the polymer coating would not
affect cell viability.
In one of the most in-depth studies on the interaction
between anisotropic magnetic nanoparticles and cells, Berret
and co-workers showed that polymer-coated iron oxide nano-
wires without any targeting ligands on their surface could also
be internalized by NIH/3T3 fibroblast cells after 24 h incu-
bation.76 Phase contrast microscopy revealed that the cells
maintained their shape and adherence properties after 24 h
incubation with nanowires and confirmed the presence of
wires of different lengths (1–7 μm) inside cells (Fig. 12a–c).
The authors further investigated the potential cytotoxicity of
the nanowires and their spherical iron oxide building blocks
in order to establish the influence of the nanomaterial’s mor-
phology on cell viability. Cell proliferation, mitochondrial
activity measurement and reactive oxygen species (ROS) pro-
duction revealed no short-term (<100 h) toxicity of either type
of nanomaterial. Interestingly, TEM pictures acquired after a
24 h incubation with 15 μm nanowires showed that three types
of nanomaterials could be observed inside intracellular com-
partments (surrounded by lipidic membranes, Fig. 12d,
images 1 and 2) or in the cytosol (Fig. 12d, images 3 and 4),
but not inside the nuclei: nanowires (entire or pieces), clusters
of spherical nanoparticles and nanoparticles alone. This indi-
cated that cells were able to degrade the initial nanowires and
the degradation was attributed to the low pH inside lysosomal
compartments and to the structure of the wires, which were
composed of spherical nanoparticles held together by non-
covalent interactions. In contrast, spherical nanoparticles
were observed only inside membrane-bound compartments
(Fig. 12d, images 5 and 6), suggesting a different cell internal-
ization pathway depending on the shape of the nanomaterial.
Immunofluorescence studies using lysosomal associated mem-
brane protein 1 (LAMP1) markers confirmed the subcellular
Fig. 11 (a) Internalization of spherical (NS) and high aspect ratio nanomaterials (nanoworms, NW) functionalized with F3 peptide by MDA-MB-435
cells. Top: elongated shape enables multivalent interactions between F3 peptides and cell-surface receptors. Middle: comparison of the internali-
zation efficiency for different NS and NW formulations, obtained from fluorescence data. Bottom: fluorescence microscope images after 3 h of incu-
bation of cells with NWs and NS modified with fluorescent FITC F3 peptides (green). Nuclei are stained with DAPI (blue). FITC: fluorescein
isothiocyanate. Scale bars are 2 μm. Adapted from ref. 4 with permission from John Wiley & Sons. (b) Top: systematic surface engineering of nano-
materials for optimal in vivo tumour targeting. Three parameters – shape (blue oval), linker structure (red oval) and targeting peptide (green circle) –
were optimized. Bottom: near infrared (NIR) fluorescence images of mice bearing MDA-MB-435 and HT1080 tumours obtained 24 h after injection
with different NW formulations. Arrows and arrowheads indicate the tumours and the livers, respectively. Reprinted from ref. 5 with permission from
John Wiley & Sons.
Nanoscale Review
This journal is © The Royal Society of Chemistry 2015 Nanoscale, 2015, 00, 1–28 | 17
1
5
10
15
20
25
30
35
40
45
50
55
1
5
10
15
20
25
30
35
40
45
50
55
localization of the wires, although further studies are needed
to unravel the internalization mechanism. The fact that the
nanowires could be degraded inside cells without showing
signs of cytotoxicity associated with other high aspect ratio
nanomaterials107 is a positive feature for possible bioapplica-
tions of such nanostructures.
Despite the increasing number of bioapplications of carbon
nanotubes, there is still no consensus regarding their toxicity
and adverse effects.108 In addition, the potential cytotoxicity,
biodistribution and elimination of hybrid CNT-magnetic nano-
materials would require a more in-depth investigation, as each
individual component is expected to contribute to the overall
toxicity of the material. In the reports published so far, hybrid
CNT materials generally showed low toxicity on different cell
lines and in one in vivo example, although cell viability was
evaluated using different assays and the concentration range
employed was not the same for all nanomaterials. Moreover,
no detailed investigations on the fate of the hybrids after cell
internalization have been carried out. Only one observation
has been made in this regard by Bégin-Colin and co-workers,
who pointed out that CNTs decorated with iron oxide nanopar-
ticles were internalized by human prostate cancer cells (PC3)
without signs of cytotoxicity or detachment of the iron oxide
NPs from the CNT surface.57 Therefore, more data are needed
to obtain a global picture about the cytotoxicity and degra-
dation mechanisms of this kind of high aspect ratio nanoma-
terial. Multiwalled carbon nanotubes–iron oxide (MWCNT-IO)
hybrids reported by Yang and co-workers showed very low
in vitro toxicity on MCF-7 (human breast adenocarcinoma) and
L929 (mouse fibroblast) cell lines even at high concentrations
(more than 80% cell viability after 24 h exposure to a concen-
tration of 200 μg mL−1).54 These hybrids displayed a negligible
haemolytic effect on human red blood cells, indicating their
suitability for intravenous administration. The in vivo behav-
iour of the MWCNT–IO hybrids was investigated in mice after
tail vein injection using histopathology and TEM microscopy
to assess their biodistribution and inductively coupled
plasma–atomic emission spectroscopy (ICP–AES) to determine
the amount of Fe in organs. ICP results showed that the liver,
lung and spleen were responsible for the uptake of the hybrids
and no significant amounts were found in the heart and
kidneys. At short times (4 h post-injection) the hybrids accu-
mulated preferentially in the liver, while after prolonged
exposure (8 h) they were found mainly in the spleen. Elimin-
ation studies revealed that the MWCNT–IO hybrids were
mainly excreted in faeces, although a small amount of Fe
was also found in urine up to 24 h after injection. Lu et al.
evaluated the cellular uptake and in vitro cytotoxicity of
Fig. 12 Interaction of magnetic iron oxide nanowires with NIH/3T3 fibroblast cells. (a, b) Phase contrast microscopy images of cells incubated with
15 μm nanowires for 24 h. Yellow arrows in panel (b) indicate internalized wires of different lengths. (c) Schematic representation of the area
depicted in image (b). (d) TEM images of internalized nanowires (images 1–4) and nanospheres (5 and 6) after 24 h. Images in the right column (2, 4
and 6) represent zoom-ins of the yellow rectangles in images 1, 3 and 5. Red arrows in images 1 and 4 indicate single nanoparticles resulted from
degradation of nanowires. Top: nanowires inside intracellular compartments. Middle: nanowires dispersed in the cytosol. Bottom: spherical nano-
particles internalized in membrane-bound compartments. Reprinted with permission from ref. 76. Copyright 2011, American Chemical Society.
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polymer-coated MWCNT–IO hybrids decorated with folic acid
(FA) as the tumour targeting ligand.55 Folate receptors are over-
expressed on the surface of several types of cancer cells and
folate-mediated targeting has been widely explored for diag-
nostics and therapeutic purposes.109 FA–MWCNT–IO hybrids
showed increased cellular uptake through receptor-mediated
endocytosis in U87 (human glioblastoma cells); the uptake was
significantly diminished when folate receptors on U87 cells
were blocked with folic acid prior to incubation with the nano-
tubes. MTT cell viability assays carried out after two days of
incubation with FA–MWCNT–IO hybrids confirmed their low
toxicity on both cancer cells (U87) and normal cells
(3T3 mouse fibroblasts) over a broad range of concentrations
(0.001–1000 μg mL−1). Similarly, Yin et al. reported improved
cellular uptake of FA-conjugated magnetic CNT hybrids in
HeLa (human cervical cancer) cells when compared to mag-
netic CNT hybrids lacking the folic acid targeting units.56
3.3 Magnetic separation and detection
Magnetic separation of cells and biomolecules is one of the
most widespread applications of magnetic nanoparticles. The
separation principle is generally based on recognition events
between the cells or biomolecules of interest and magnetic
nanoparticles with appropriate surface functionalization (e.g.
antigen–antibody interactions or hybridization of complemen-
tary oligonucleotide strands).13,110–112 Naturally, high aspect
ratio magnetic nanomaterials were also explored for biosepara-
tions, as their higher magnetic moment and ability to estab-
lish multivalent interactions with cells and biomolecules were
thought to improve the yield of separation.
In one of the first examples of cell separation with aniso-
tropic magnetic nanomaterials, Reich and co-workers showed
that ferromagnetic Ni nanowires (35 μm length, 350 ± 40 nm
diameter) performed better than commercially available super-
paramagnetic beads of comparable volume in the separation
of mouse NIH-3T3 fibroblast cells.40 The separation yield was
higher by about a factor of two for the nanowires when com-
pared to the beads (49 ± 3% vs. 19 ± 2%), which was attributed
to the larger surface area and higher magnetic moment of the
wires.
Mirkin and co-workers reported the use of triblock mag-
netic Au–Ni–Au nanorods for the separation of proteins and
antibodies using specific Ni–histidine (His) and biotin–strepta-
vidin binding strategies. In a first example, when the rods were
exposed to a mixture of His-tagged and non-tagged proteins,
the proteins bearing the histidine tag attached to the Ni seg-
ments of the rods and could be easily separated by applying
a magnetic field (Fig. 13a, route 1).44 Furthermore, using
nanorods with the Au segments functionalized with nitro-
streptavidin, the authors performed a simultaneous separation
of a mixture of three proteins: a non-tagged protein, biotin-
tagged BSA and His-tagged ubiquitin (Fig. 13b).45 The separ-
ation efficiency of His-tagged and biotin-tagged proteins was
higher than 90%, based on fluorescence measurements. Simi-
larly, Au–Ni–Au nanorods functionalized with poly-His were
employed to separate a mixture of fluorescently labelled
anti-human immunoglobulin G (IgG) and anti-poly-His IgG
(Fig. 13a, route 2).44
Son et al. employed magnetic nanotubes decorated with
human IgG on their inner surface to selectively separate fluor-
escently labelled anti-human IgG from a solution containing
also anti-bovine IgG.51 Fluorescence spectra revealed that 84%
of the anti-human IgG was separated by IgG-nanotubes, while
in a control experiment using magnetic nanotubes functiona-
lized with bovine serum albumin (BSA), the nonspecific separ-
ation yield was significantly lower (9%).
Dextran-coated iron oxide (DION) superparamagnetic
nanorods conjugated with anti-MAP antibodies (MAP = Myco-
bacterium avium spp. paratuberculosis) were efficiently used as
magnetic sensors for the detection of bacteria.27 Due to their
magnetic and shape anisotropy, the rods were superior to
similar spherical nanoparticles,113 both in terms of kinetics
and limit of detection. The improved limit of detection
observed was attributed to the possibility of introducing a high
number of antibodies on the surface of the nanorods when
compared to the spherical nanoparticles. Prina-Mello et al.
also took advantage of the high aspect ratio of fluorescent
Fig. 13 Multisegment Au-magnetic nanorods for bioseparations. (a)
Separation of proteins (route 1) and antibodies (route 2). Cuvettes in
image 1 show a solution of fluorescein-tagged poly-histidine before and
after magnetic separation. The orange cuvette in image 2 shows a
mixture of His-tagged (red) and untagged (green) proteins. After
exposure to Au–Ni–Au nanorods, the His-tagged protein is removed
(thus the green colour observed in the middle cuvette containing the
untagged protein). The red solution observed in the right hand-side
cuvette is due to the release of the His-tagged protein. Reprinted from
ref. 37 with permission from John Wiley and Sons. (2) Simultaneous
separation of a tricomponent mixture of His-tagged, biotin-tagged and
untagged proteins using Ni–His and biotin–streptavidin interactions.
Reprinted with permission from ref. 45. Copyright 2006, American
Chemical Society.
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magnetic nanowires to maximise the efficiency of nanowire-
cell binding for immunodetection applications using flow
cytometry.50 Multiple copies of primary IgG antibody R-phy-
coerythrin (R-PE) conjugated to secondary human CD54 (intra-
cellular adhesion molecule 1, ICAM-1) functionalized with
fluorescein were introduced on the surface of the wires, result-
ing in a uniform coverage. Once again, nanowires outper-
formed their spherical analogues for the detection of human
acute monocytic leukemia cells (THP-1) binding to ICAM-1.
Although the percentage of cells binding to nanospheres was
higher than that binding to wires (62% vs. 17%), the nanowires
were used at a much lower concentration (1.00 × 107 mg mL−1)
than the spherical nanoparticles (6.50 × 108 mg mL−1). More-
over, the nanowires did not show any tendency to form clusters
in solution, as opposed to spherical nanoparticles, which rep-
resents an additional advantage for multiplexed flow cytometry
applications.
3.4 Targeted drug delivery
The main advantages of targeted delivery of therapeutics over
topical application are a better efficacy because of the high
local concentration of drug and reduced adverse effects due to
a very low systemic exposure. Cancer is particularly attractive
for targeted delivery for two reasons. On the one hand, tumour
cells and vasculature present characteristics that distinguish
them from healthy cells and blood vessels, expressing specific
molecules that can be used for selective recognition by delivery
vehicles (see the review by Ruoslahti et al.114). On the other
hand, targeted delivery of anticancer compounds would
reduce the exposure of healthy tissues to aggressive chemo-
therapeutics, while ensuring a high local concentration of
drug, thus alleviating important problems of traditional
cancer therapy methods.12
Nanomaterials present unique opportunities for the tar-
geted delivery and controlled release of the drug. In particular,
engineered magnetic nanoparticles can perform cooperative
targeting, diagnostic (MRI) and therapeutic (drug release and/
or magnetic hyperthermia) functions and, due to their mag-
netic properties, their targeting can be improved by magnetic
guidance. Nevertheless, designing nanoparticles for drug deli-
very is a challenging task. As indicated in section 3, nano-
materials for biomedical applications must be robust enough
to overcome a series of biological barriers and reach their
target in a pharmaceutically relevant concentration and
without loss or alteration of their function. In addition, the
distinct features of tumour cells and vasculature, although
providing specific markers for targeting, make difficult the
access of nanomaterials to the majority of cancer cells.
High aspect ratio nanomaterials can be decorated with mul-
tiple recognition elements to improve their tumour targeting
by establishing multivalent interactions with markers present
on the surface of cancer cells. Sailor and Ruoslahti extensively
exploited this feature to develop more efficient targeting and
delivery systems based on anisotropic nanomaterials. Their
initial work using superparamagnetic iron oxide nanoworms
(NWs) focused on the optimization of the tumour targeting
efficiency by tuning the surface functionalization of the nano-
material (see also section 3.2).4,5 Different peptides were
explored as targeting elements, based on the fact that many
peptides are known to have cell- and tumour-penetrating pro-
perties115 or can act as tumour vasculature markers.116–118
Multifunctional nanoworms decorated with a chimeric peptide
composed of a tumour vasculature targeting element (CGKRK)
and a therapeutic agent (D[KLAKLAK]2, known to initiate apop-
tosis by disrupting the membrane of mitochondria) were
explored as potential therapy for glioblastoma.119 The system
was tested in murine models for two types of brain tumours
and succeeded in eliminating most lentiviral-induced brain
tumours in mice and increasing the survival period of mice
with more aggressive U87 glioblastoma. The exceptional effec-
tiveness of this therapeutic nanomaterial is due to several key
design elements. On the one hand, the targeting component
CGKRK not only targeted the tumour vasculature, but also
mitochondria, ensuring the subcellular targeted delivery of the
therapeutic payload D[KLAKLAK]2. Nanoworms bearing only
the proapoptotic peptide (without the homing peptide)
showed no targeted delivery and were not effective against
brain tumours. On the other hand, the elongated geometry of
the iron oxide nanoworms enhanced the cell internalization
due to multivalent interactions (vide supra). Targeted subcellu-
lar delivery and multivalent presentation on elongated nano-
carriers made possible the lowering of the necessary dose of
D[KLAKLAK]2 by 100-fold, which reduced the adverse effects
associated with the high toxicity of the peptide at therapeutic
doses. Co-administration of the CGKRKD[KLAKLAK]2-NWs
together with the tumour-penetrating peptide iRGD further
improved the efficacy of the treatment by allowing the nano-
particles to reach the tumour cells in addition to tumour
blood vessels. Finally, the magnetic properties of the nano-
worms were used to further confirm their localization inside
brain tumours on magnetic resonance images.
The nanoworms were further employed as part of coopera-
tive nanomaterial systems for amplified tumour targeting and
therapy purposes.120 Au nanorods (NRs) that passively accumu-
late in tumours were used to induce photothermal activation
of the tumour microenvironment by absorption of near-infra-
red (NIR) radiation. This in turn amplified in vitro tumour
targeting by magnetic nanoworms (NWs) decorated with LyP-1,
a cyclic nine amino acid peptide that selectively binds p32
receptors overexpressed on the surface of certain types of
cancer cells upon exposure to thermal stress. Mice with
MDA-MB-435 human carcinoma tumours and C8161 human
melanoma (whose level of p32 receptors is much lower than
that for MDA-MB-435) were injected with control NWs and
LyP1NWs to examine the possibility of selective in vivo tumour
homing. Increased cellular uptake of LyP1NWs was observed
in MDA-MB-435 tumours upon heating to 45 °C in a water
bath for 30 min when compared to unheated tumours. Conver-
sely, the ability of the nanoworms to target heated and non-
heated C8161 tumours was not significantly different. Simi-
larly, the authors demonstrated that in vivo MDA-MB-435
tumour targeting of therapeutic nanoparticles (LyP1 liposomes
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carrying doxorubicin) was significantly enhanced by NR-
mediated photothermal heating. Moreover, although photo-
thermal therapy alone could not reduce tumour volumes, its
combination with therapeutic nanoparticles revealed substan-
tial tumour regression and even eradication. The authors
explained the success of their cooperative therapy by the fact
that cells exposed to NR-heating were more sensitive to sub-
sequent exposure to chemotherapy.
Using an ingenious design inspired by communication in
biological systems, Bhatia and co-workers developed a two-
component nanosystem to amplify in vivo targeting. The
system consists of a “signalling” module (nanoparticles or pro-
teins) that targets tumours and then transmits their location
to a “receiving” module (circulating nanoparticles carrying
diagnostic or therapeutic payloads) through the activation of a
biological cascade (Fig. 14a).121 The authors chose the coagu-
lation process as a tool for transmitting communication
between signalling (Au nanorods or tumour-targeted tissue
factor tTF-RGD) and receiving (multimodal magnetic-fluo-
rescent iron oxide nanoworms or doxorubicin-loaded lipo-
somes) components using two molecular pathways: activity of
coagulation transglutaminase factor XIII (FXIII) or targeting of
polymerized fibrin. Signalling modules induced coagulation in
tumours through photothermal conversion of NIR radiation
(Au NRs) or by binding to angiogenic αvβ3 receptors in tumour
vasculature (tTF-RGD). Receiving nanoparticles were engin-
eered to target coagulation regions in tumours and deliver
imaging or therapeutic agents. Accordingly, nanoworms and
liposomes were functionalized with factor XIII substrates or
fibrin-binding peptides to address both molecular pathways in
the coagulation cascade. The capacity of the integrated system
to communicate and amplify in vivo tumour targeting and
drug delivery was evaluated in mice bearing MDA-MB-435
tumours. FXIII-NWs showed more than one order of magni-
tude increase in accumulation in tumours following NR
administration and thermal NIR irradiation when compared to
unirradiated tumours. Similarly, tTF-RGD signalling modules
co-injected with the nanoworms amplified their tumour target-
ing by several-fold over non-communicating systems. It is note-
worthy that this strategy significantly improved the delivery of
therapeutic nanoparticles to tumours, with a 40-fold increase
in the accumulation of doxorubicin-loaded liposomes com-
pared to liposomes alone.
A similar amplification system based on communication
between signalling and receiving nanoparticles was further
designed using changes in the tumour microenvironment to
mediate increased targeting.122 The system was composed of
signalling Au nanorods and responding magnetic nanoworms
(Fig. 14b). Upon NIR irradiation, Au NRs induced denaturation
of Type I collagen present in the extracellular matrix of tumour
cells, thus altering its tri-helical tertiary structure and exposing
cryptic epitopes to fibronectin-functionalized magnetic nano-
worms (FnF-NWs) for selective targeting of denatured collagen.
This cooperative system resulted in a six-fold enhancement in
Fig. 14 Amplification of tumour targeting with communicating nanoparticles. (a) Schematic representation of the communication system involving
signalling modules (Au nanorods or engineered proteins) that use a biological cascade (coagulation) to transmit the information to receiving com-
ponents (inorganic magnetic nanoworms or organic drug-loaded liposomes). Adapted from ref. 121 by permission from Macmillan Publishers Ltd
(Nat. Mater., 2011, 10, 545), copyright 2011. (b) Photothermal denaturation of collagen exposes cryptic binding sites for recognition by fibronectin-
conjugated magnetic nanoworms, resulting in enhanced tumour targeting. Reprinted from ref. 122 with permission from The Royal Society of
Chemistry.
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binding of the FnF-NWs over non-heated controls or experi-
ments using control substrates (albumin) and control target-
ing moieties on the receiving nanoworms (albumin-NWs).
Although the ability of the system to induce nanoparticle
amplification was tested only in vitro, it can be anticipated that
this approach would be successful in vivo, as local hyperther-
mia induced by the Au NRs would trigger changes in the
tumour vasculature, making possible the recruitment of the
responding nanoparticles. Another attractive feature of this
approach is the fact that it displays binding sites that are not
normally accessible under physiological conditions, while
other typical receptor-mediated nanoparticle delivery systems
require upregulation of cell-surface receptors.120
Peiris et al. developed a multicomponent nanomaterial for
enhanced delivery of chemotherapeutics consisting of three
iron oxide nanospheres and one doxorubicin-loaded liposome
covalently assembled in a nanochain89 with a length of
100 nm.90 The magnetic nature of the nanoparticles was used
to trigger the controlled release of the drug from the liposomes
upon exposure to a radiofrequency (RF) field (Fig. 15). Mechan-
ical vibrations induced by oscillations of the magnetic nano-
particles were thought to be responsible for the controlled
release of the drug by causing defects in the liposome mem-
brane. This release mechanism was confirmed by the fact that
the release was concentration-independent, but significantly
affected by the distance from the RF coil. The nanochains out-
performed 100 nm spherical doxorubicin-loaded liposomes
both in terms of blood circulation time (26 h half-life com-
pared to 18 h for 100 nm liposomes) and intratumoral uptake
in mice bearing 13762 MAT BIII mammary adenocarcinoma.
Application of an RF field 24 h after the intravenous adminis-
tration of the nanochains resulted in significant inhibition of
tumour growth, as opposed to conventional doxorubicin or
liposome-doxorubicin treatment.
3.5 Magnetic resonance imaging (MRI)
Magnetic resonance imaging (MRI) is a non-invasive imaging
technique widely employed for diagnostic purposes based on
high-resolution anatomical information, resulting from the
different magnetic surroundings of the protons in water mole-
cules in tissues. Magnetic nanoparticles are commonly used as
contrast enhancement agents for MRI due to their ability to
shorten the transverse relaxation times (T2 and T2*) of water
protons in their vicinity.9,10,16 This results in the darkening of
the tissue containing magnetic nanoparticles, therefore the
name of “negative” contrast agents (as opposed to rare earth
metal complexes that are used as “positive” contrast agents by
reducing the longitudinal relaxation time T1). Some of the
high aspect ratio magnetic nanomaterials described in the lit-
erature have shown great potential as MRI contrast agents, in
some instances surpassing their spherical counterparts. Never-
theless, most examples report data obtained in solution or
phantom media and more in vitro and in vivo studies are
needed in order to have a clearer global picture of the real
potential of such nanomaterials.
The efficiency of a contrast agent is typically measured in
terms of longitudinal and transverse relaxivities (R1 = 1/T1 and
R2 = 1/T2), defined as the increase of the relaxation rate of
water produced by 1 mmol L−1 of the active ion (Gd, Fe, etc.).10
Usually, R is plotted against Fe concentration and the slope of
the curve yields the concentration-independent relaxivity (r1, r2).
Gun’ko and co-workers investigated the nuclear magnetic
resonance dispersion (NMRD) profile of chains of iron oxide
nanoparticles assembled on single-stranded and double-
stranded DNA,59 respectively on PSSS.17 DNA composites
showed unusually high r1 relaxivities at low magnetic field,
especially in the case of the single-stranded assembly. The
authors reasoned that the better ordering on denatured DNA
templates, resulting in a higher concentration of magnetic
nanoparticles, might be the cause of the unexpected high r1
value. NMRD curves of PSSS assemblies of magnetic nanopar-
ticles showed higher values for the r2 relaxivity when compared
to r1 at different magnetic fields and temperatures. The PSSS
composites were evaluated for in vivo MR imaging in rats.
Although the authors did not report extensive toxicity and bio-
distribution data, they mention no signs of adverse reactions
after 24 h of injection. MR images obtained at 7 T using Echo
Planar Imaging (EPI) and Fast Low Angle Shot (FLASH)
sequences before and after injection of the nanomaterial into
the tail vein of rats showed that this reached the brain after
approximately 12 s (Fig. 16a), and the occlusion of the sinus
superior sagittalis (SSS) vein could be clearly identified on the
FLASH image. Based on these initial observations, the authors
acknowledged the potential of high aspect ratio magnetic
nanoparticles for in vivo MRI and attributed their easy circula-
tion through the blood vessels to their elongated shape.
However, no comparison with the individual spherical build-
ing blocks was carried out in this regard.
Superparamagnetic iron oxide nanoworms described by
Sailor and co-workers showed better contrast and higher r2
relaxivities at 4.7 T in solution (116 mM−1 s−1) when compared
to similar spherical nanoparticles (70 mM−1 s−1) and commer-
cially available Feridex (95 mM−1 s−1).4 The initial explanation
of the authors attributed the result to the linear aggregation of
spherical iron oxide nanoparticles, which might result in
enhanced spin–spin relaxation of water molecules. In a more
Fig. 15 (a) Radio-frequency induced tuneable drug release from mag-
netic nanochains exploiting defects in the liposomal membrane induced
by mechanical vibrations of the magnetic nanoparticle chain. (b) In vitro
triggered release of doxorubicin from different nanocarriers using an RF
field at 10 kHz. Reprinted with permission from ref. 90. Copyright 2011,
American Chemical Society.
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elaborate study, the authors further investigated the magnetic
properties of the nanoworms and obtained the NMRD profile
at different temperatures.18 A linear increase of the r2 relaxivity
with the magnetic field was observed and the obtained values
were consistent with numerical simulations conducted both
on individual spherical nanoparticles and linear clusters.18,123
Similarly, Peiris et al. reported a 2.5-fold increase in the trans-
verse relaxivity of nanochains assembled by covalent linking of
three spherical nanoparticles when compared to individual
nanoparticles.89 This linear chain showed an r2 value of
101 mM−1 s−1 at 1.4 T and 40 °C, superior to that reported by
Sailor and co-workers for the nanoworms18 (64.8 mM−1 s−1 at
the same magnetic field and 37 °C).
Wu et al. reported a comprehensive in vitro and in vivo
study of MWCNT–IO hybrids as potential MRI contrast
agents.54 Water suspensions of MWCNT hybrids with different
Fe concentration were imaged at 3.0 T in a clinical MRI
scanner at room temperature, showing a decrease in signal
intensity with increasing concentration of iron (Fig. 16b).
Images of MCF-7 cells incubated with different concentrations
of MWCNT–IO hybrids also revealed a significant negative con-
trast enhancement. The decrease in the MRI signal was higher
at higher concentrations of contrast agent, due to the
enhanced cellular uptake. Finally, the authors explored the
potential of the MWCNT–IO hybrids for in vivo imaging. T2-
Weighted MR images were acquired before and at different
time points after the injection of the hybrids in the tail vein of
mice at a dose of 2.5 mg Fe per kg body weight. The significant
decrease in the signal intensities of liver and spleen revealed
that these two organs were responsible for the relatively quick
uptake (15 min) of the MWCNT–IO hybrids (Fig. 16c). Jia and
co-workers investigated water-dispersible carbon nanotubes
decorated with iron oxide nanoparticles as novel contrast
agents for MRI.56 These CNT hybrids showed promising
results both in solution and in vitro. However, the authors
reported the efficiency of their contrast agent in terms of
effective transverse relaxivity (r2* = 263 mM−1 s−1 at 3.0 T; the
effective transverse relaxation time T2* takes into account mag-
netic field inhomogeneities and is always smaller than T2),
therefore a comparison with similar carbon nanotube-based
contrast agents cannot be made. To evaluate the potential of
the nanotubes for MRI targeted cancer detection, HeLa cells
were incubated with two types of magnetic CNTs, one functio-
nalized with folic acid as the targeting unit and one without
and MRI images were acquired after 6 h (see also section 3.2).
Cells incubated with the nanotubes functionalized with folic
acid showed lower T2* relaxation times and higher negative
contrast than those incubated with the nanomaterial lacking
the targeting moiety. This observation confirms the impor-
tance of ensuring the cellular uptake of a contrast agent
through its appropriate surface functionalization. Lamanna
et al. reported that carbon nanotubes decorated with iron
oxide nanoparticles using the ligand exchange approach Q5(see
page 6) showed a slightly lower longitudinal relaxivity
(13 mM−1 s−1) than the corresponding spherical IO nanoparti-
cles (19 mM−1 s−1). This could be explained by the fact that
the proton accessibility to magnetic centres is impaired by the
aggregation of the NPs on the surface of the CNTs. On the
other hand, the transverse relaxivity showed a slight increase
(from 88 mM−1 s−1 for the NPs alone to 103 mM−1 s−1 for the
nanotube hybrids), which was attributed by the authors to the
larger local magnetic field produced by the assembly of the
Fig. 16 (a) In vivo evaluation of magnetic nanowires as MRI contrast agents. EPI (1 and 2) and FLASH (3 and 4) scans of mouse brain before and
after injection of the magnetic nanomaterial (see text for abbreviation of the MRI pulse sequences). Reprinted with permission from ref. 17. Copyright
2008, American Chemical Society. (b) MWCNT–IO hybrids as contrast agents for MRI. T2-Weighted MR images of water suspensions of MWCNT–IO
hybrids with different concentrations (top) and plot of the relaxation time against Fe concentration (bottom). (c) In vivo T2-weighted images of liver
(top), spleen and kidneys (bottom) at different time points after intravenous administration of the MWCNT–IO hybrids. Reprinted from ref. 54, H. Wu
et al., The behavior after intravenous injection in mice of multiwalled carbon nanotube/Fe3O4 hybrid MRI contrast agents, Biomaterials, 32,
4867–4876, Copyright 2011, with permission from Elsevier.
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NPs. Cells incubated with the CNT–NP hybrids could be
detected by MRI in agarose gels as hypointense areas whose
density was proportional to the number of cells seeded in the
gels. This observation suggests that such CNT–NP nanocon-
structs have potential as MRI contrast agents for cell tracking.
The group of Ivanisevic devoted much effort to the develop-
ment of efficient MRI contrast agents based on DNA-templated
high aspect ratio magnetic nanomaterials.60–65 The authors
investigated different chain compositions (Au, Fe2O3 or
CoFe2O4 single- and multicomponent chains), DNA :
nanoparticle (NP) ratios, as well as LBL-encapsulated vs. non-
encapsulated DNA-chains. DNA–NP chains shortened the
transverse relaxation times when compared to individual
nanoparticles, with the exception of single-component Au NP
chains, in which no difference could be appreciated between
the chains and the Au NPs. Although for DNA : NP ratios of
1 : 5 and 1 : 10 the observed shortening in T2 was more pro-
nounced than for the 1 : 1 ratio, these chains had poorer col-
loidal stability and were not further investigated. The proposed
relaxation mechanism suggests that the shortening of T2 relax-
ation times was due an increase in the magnetization upon
magnetic nanoparticle alignment on the DNA template as well
as to possible inter-segment interactions that could also alter
the overall magnetization of the system (Fig. 17a).65 Optimised
single- and multicomponent chains were then subjected to an
exhaustive MRI study in cell culture phantoms, in order to
mimic in vivo environments (Fig. 17b).64 Table 2 summarizes
the transverse relaxivities obtained in a clinical 3 T MRI
scanner for several DNA–NP constructs both before and after
LBL encapsulation. Studies were conducted in Matrigel (a gela-
tinous protein mixture resembling the extracellular environ-
ment) and in 3D cell cultures in Matrigel. These experiments
can provide a quick and inexpensive assessment of the
efficiency of MRI contrast agents prior to in vivo studies. In
Matrigel, single-component magnetic chains, as well as Au-
magnetic multicomponent chains, showed a remarkable
increase in r2 values compared to dispersed nanoparticles (up
to 12-fold in the case of Au–Fe2O3 chains). However, in 3D cell
cultures there were no significant differences between NPs and
NP chains, and the measured values were generally lower than
those measured in Matrigel alone. Previous observations on
2D cell cultures indicated that chains and nanoparticles were
both internalized by cells in a similar fashion and accumu-
lated into vesicles, independent of their shape.63 The authors
postulated that this agglomeration was responsible for the
Fig. 17 (a) Proposed mechanism for the relaxation induced by DNA-Au-magnetic nanoparticle chains. Reprinted from ref. 65 with permission from
The Royal Society of Chemistry. (b) T2-Weighted MR images showing contrast in Matrigel and 3D cell culture scaffolds using DNA-templated nano-
particle chains. For a depiction of the chain structures, see Fig. 6. Reprinted with permission from ref. 64. Copyright 2011, American Chemical
Society.
Table 2 Transverse relaxivities for single-component and multicompo-
nent nanoparticle chains in Matrigel and in 3D cell cultures compared to
dispersed nanoparticles. Adapted with permission from ref. 64. Copy-
right 2011, American Chemical Society
Nanomaterial
r2 (mM−1 s−1)
Dispersed
NPs NP chains
Encapsulated
NP chains
Matrigel Single component
Au 10.1 ± 5.8 10.0 ± 6.0 —
Fe2O3 12.2 ± 0.3 78.6 ± 5.8 —
CoFe2O4 21.7 ± 15.6 114.0 ± 34.0 —
Multicomponent
Au–Fe2O3 9.7 ± 6.0 120.4 ± 12.6 75.4 ± 8.1
Au–CoFe2O4 21.3 ± 1.5 89.5 ± 11.0 55.5 ± 16.6
Cells in
Matrigel
Single component
Au 5.0 ± 1.2 2.5 ± 2.0 —
Fe2O3 4.6 ± 3.4 12.3 ± 8.0 —
CoFe2O4 8.0 ± 4.7 11.8 ± 7.4 —
Multicomponent
Au–Fe2O3 7.2 ± 4.0 8.8 ± 3.2 11.8 ± 4.8
Au–CoFe2O4 6.0 ± 4.0 13.3 ± 6.4 6.8 ± 1.3
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similar transverse relaxivity values observed for NPs and NP
chains in 3D cell cultures. Upon LBL encapsulation, a decrease
in the transverse relaxivity was observed in Matrigel phantoms.
However, in 3D cell culture phantoms no significant differ-
ences were found, as in this case MRI contrast would be gov-
erned by the cellular uptake, which improved significantly
upon encapsulation. To sum up, these studies revealed that in
phantoms the MRI contrast was clearly better when using high
aspect ratio nanomaterials. Conversely, in cell cultures the con-
trast was governed by the cell uptake efficiency rather than by
the shape of the nanomaterial.
4. Concluding remarks and
perspectives
Although much less explored than spherical nanoparticles, an-
isotropic magnetic nanomaterials possess attractive qualities
for biomedical applications. In this work we present an over-
view of the synthesis of high aspect ratio magnetic nanomater-
ials and give examples of their applications in different fields:
magnetic separation and detection, targeted delivery and mag-
netic resonance imaging, highlighting those examples in
which anisotropic nanomaterial surpassed their spherical
counterparts.
However, despite the advances in the field and the clear
promise of these nanomaterials, research on this topic is still
in its infancy and several challenges need to be addressed. In
our opinion, the following two aspects deserve special atten-
tion and a more thorough investigation in the future:
(1) Synthesis optimization. Despite obvious progress and
some very elegant approaches reported, there is a need to opti-
mize the synthesis of anisotropic magnetic nanomaterials.
Ideally, cheap, general and high-throughput synthetic pro-
cedures allowing for reproducible, large-scale synthesis of high
aspect ratio magnetic nanomaterials with good control over
their shape and magnetic properties are desirable. Probably
the most successful routes will focus on electrodeposition in
porous templates and assembly from individual building
blocks. The use of templates permits an excellent control over
the shape of the resulting anisotropic nanomaterials and
offers the possibility of constructing multi-segmented nano-
structures. Creating linear assemblies from spherical magnetic
nanoparticles enables a good control of the length and the
magnetic properties of the resulting linear assembly (usually,
the resulting high aspect ratio preserves the magnetic pro-
perties of the initial individual components). Moreover, this
method would capitalize on some already optimized methods
for the synthesis of spherical magnetic nanoparticles. Last but
not least, research in the field of high aspect ratio magnetic
nanoparticles would definitely benefit from more in-depth
mechanistic studies (including theoretical calculations) to
unravel the mechanism of formation of such nanostructures.
(2) Investigation of the cytotoxicity and interaction with bio-
logical entities. The development of novel nanomaterials inevi-
tably raises questions related to their potential toxicity. As
high aspect ratio nanomaterials interact with cells in signifi-
cantly different ways when compared to spherical nanoparti-
cles, it is essential to assess their internalization pathways,
effect on cell viability and degradation routes. Some detailed
studies in this direction have already been reported; however,
more research needs to be done in order to gain a better
understanding of the cytotoxicity of anisotropic nanomaterials.
A very important aspect is to relate the toxic effects to the size
and concentration of high aspect ratio nanomaterials. For
instance, some studies seem to indicate that short Ni nano-
wires are less toxic than longer ones, but at this point we are
far from able to generalize their behaviour. Systematic studies
using different cell lines and types of assays would shed more
light on the interaction of anisotropic magnetic nanomaterials
with cells and would provide useful information prior to in
vivo studies.
The superiority of anisotropic magnetic nanomaterials over
their spherical analogues has been demonstrated in some of
the examples discussed in this review. Especially in the case of
targeted drug delivery and magnetic resonance imaging appli-
cations, there is clear evidence to relate improved cell targeting
and better magnetic properties to the shape and magnetic an-
isotropy. Therefore, we are confident that the field will con-
tinue its growth in the coming decades and the quest for new,
exciting applications of high aspect ratio nanomaterials in bio-
medicine will follow. In particular, we believe that three areas
could capitalize on the unique properties of these high aspect
ratio nanostructures. Firstly, they could become valuable MRI
diagnostic tools for the early detection of tumours and other
disorders, due to their good magnetic sensitivity. Secondly,
although barely investigated to date, the use of anisotropic
magnetic nanomaterials for hyperthermia therapy of cancer is
definitely worth exploring, as it could lead to better thera-
peutic solutions. Thirdly, anisotropic magnetic nanomaterials
could improve the efficacy of existing targeted drug delivery
systems based on nanotechnology approaches.
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